This electronic file (PDF) has embedded CVN technology (CVN-XML). The CVN technology of this file allows you to export and import curricular data from and

to any compatible data base. List of adapted databases available at: http://cvn.fecyt.es/

Juan Carlos ReverterCalatayudGenerated from: Editor CVN de FECYTDate of document: 22/01/2021v 1.4.3ce46abfe1b997dc092066835783957ac

ce46abfe1b997dc092066835783957ac

2

Summary of CV

This section describes briefly a summary of your career in science, academic and research; themain scientific and technological achievements and goals in your line of research in the medium-and long- term. It also includes other important aspects or peculiarities.

MD from the University of Barcelona (UB) (1982).He completed his MIR specialization in hematology and hemotherapy at the Hospital Clínic deBarcelona (1986). PhD from the University of Barcelona (1990).In 1994 he completed postdoctoral training at Mount Sinai Hospital in New York (USA) and atthe School of Medicine of the City University of New York, as Research Assistant Professor.He is currently head of the Hemotherapy and Haemostasis Service at the Hospital Clínic deBarcelona, since 2012.Since 2000 he is president of the Standardization Committee of the Spanish Society ofHematology and Hemotherapy.He has been president of the Catalan Society of Hematology and Hemotherapy (2009-2011),secretary of the Spanish Society of Thrombosis and Haemostasis in two periods (2003-2010and from January 2019 to September 2020).He is president of the Spanish Society of Thrombosis and Haemostasis since October 2020.He is Experts of the Scientific Committee in the European Medicines Agency (EMA).He has published more than 240 articles in international journals and 30 book chapters.He is the editor of two books. He has presented more than 200 communications andconferences in national and international congresses. His lines of research interest aredeveloped within the field of thrombosis and hypercoagulability, including: typical and atypicalthromboses (such as portal and splanic thromboses), obstetric and gynecological alterationsin relation to fertility problems and poor obstetric outcomes, antiphospholipid syndrome andantithrombotic treatment; congenital and acquired hemorrhagic diseases; and standardizationin the hematology-hemostasis laboratory.

ce46abfe1b997dc092066835783957ac

3

General quality indicators of scientific research

This section describes briefly the main quality indicators of scientific production (periods ofresearch activity, experience in supervising doctoral theses, total citations, articles in journals ofthe first quartile, H index...). It also includes other important aspects or peculiarities.

ce46abfe1b997dc092066835783957ac

4

Juan Carlos Reverter Calatayud

Surname(s): Reverter CalatayudName: Juan CarlosDNI: 46519919GORCID: 0000-0002-1274-4782ScopusID: 21335439800ResearcherID: 21335439800Date of birth: 18/07/1959Gender: MaleNationality: SpainCountry of birth: SpainAut. region/reg. of birth: CataloniaContact province: BarcelonaCity of birth: BarcelonaContact address: C/ Villarroel, 170Rest of contact address: -Postcode: 08036Contact country: SpainContact aut. region/reg.: CataloniaContact city: BarcelonaLand line phone: (0034) 932275448Fax: (0034) 932279889Email: reverter@clinic.catMobile phone: (34) 650575489

Current professional situation

Employing entity: Hospital Clínic de Barcelona Type of entity: Healthcare InstitutionsDepartment: Servicio de Hemoterapia y HemostasiaProfessional category: Jefe de Servicio de Hemoterapia y HemostasiaStart date: 2012Type of contract: Permanent employmentcontract

Dedication regime: Full time

Primary (UNESCO code): 320504 - Haematology

Previous positions and activities

Employing entity Professional category Start date1 Hospital Clinic de Barcelona Jefe de Sección de Hemostasia 20072 Hospital Clinic de Barcelona Jefe Operativo de Hemoterapia y

Hemostasia2003

3 Hospital Clinic de Barcelona Jefe de Sección Interino de Hemostasia 20024 Hospital Clinic de Barcelona Médico Adjunto del Servicio de

Hemoterapia y Hemostasia1989

5 Hospital Clinic de Barcelona 1988

ce46abfe1b997dc092066835783957ac

5

Employing entity Professional category Start dateMedico Adjunto Interino del Servicio deHemoterapia y Hemostasia

6 Hospital Clinic de Barcelona Jefe de Servicio de Hemoterapia yHemostasia

2012

1 Employing entity: Hospital Clinic de BarcelonaProfessional category: Jefe de Sección de HemostasiaStart-End date: 2007 - 2012 Duration: 5 years

2 Employing entity: Hospital Clinic de BarcelonaProfessional category: Jefe Operativo de Hemoterapia y HemostasiaStart-End date: 2003 - 2007 Duration: 5 years

3 Employing entity: Hospital Clinic de BarcelonaProfessional category: Jefe de Sección Interino de HemostasiaStart-End date: 2002 - 2003 Duration: 1 year

4 Employing entity: Hospital Clinic de BarcelonaProfessional category: Médico Adjunto del Servicio de Hemoterapia y HemostasiaStart-End date: 1989 - 2002 Duration: 13 years

5 Employing entity: Hospital Clinic de Barcelona Type of entity: Healthcare InstitutionsProfessional category: Medico Adjunto Interino del Servicio de Hemoterapia y HemostasiaStart-End date: 1988 - 1989 Duration: 1 year

6 Employing entity: Hospital Clinic de Barcelona Type of entity: Healthcare InstitutionsProfessional category: Jefe de Servicio de Hemoterapia y HemostasiaStart date: 2012

ce46abfe1b997dc092066835783957ac

6

Education

University education

1st and 2nd cycle studies and pre-Bologna degrees

1 University degree: Higher degreeName of qualification: Especialista en Hematología y HemoterapiaDegree awarding entity: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

Date of qualification: 1986

2 University degree: Higher degreeName of qualification: Licenciado en Medicina y CirugíaDegree awarding entity: Universitat de Barcelona Type of entity: UniversityDate of qualification: 1982

Doctorates

Doctorate programme: Biomedicina - Doctor en Medicina y CirugíaDegree awarding entity: Universitat de Barcelona Type of entity: UniversityDate of degree: 1990

Language skills

Language Listening skills Reading skills Spoken interaction Speaking skills Writing skillsFrench B2 B2 B2 B2 B2English C1 C1 C1 C1 C1

Teaching experience

Experience supervising doctoral thesis and/or final year projects

1 Project title: Immunothrombosis: Role of Neutrophil Extracellular Traps (NETS) in the clinical manifestations ofantiphospholipid syndrome.Entity: Máster de Medicina Traslacional - Universitat de BarcelonaStudent: Jéssica Lorena BravoDate of reading: 06/2017

2 Project title: Alteración de los factores de hipercoagulabilidad en pacientes con enfermedad de Chagas crónica:¿pueden ser considerados como marcadores de respuesta terapéutica?Entity: Universitat de Barcelona Type of entity: University

ce46abfe1b997dc092066835783957ac

7

Student: María Jesus Pinazo DelgadoDate of reading: 03/2016

3 Project title: El papel de la prueba de generación de trombina y las micropartículas circulantes como marcadorespredictores de trombosis en la enfermedad de Behçet.Entity: Universitat de Barcelona Type of entity: UniversityStudent: Juan Carlos Mejía RubianoDate of reading: 01/2016

4 Project title: Malaltia tromboembòlica venosa en el pacient oncològic: Noves formes de presentació clínica i paperdels anticossos antifosfolípid en la seva patogèniaEntity: Universitat de Barcelona Type of entity: UniversityStudent: Carme Font PuigDate of reading: 09/2012

5 Project title: Evaluación de factores clínicos y de genética plaquetaria para el desarrollo de arteriosclerosis ytrombosis arterial en pacientes con lupus eritematoso sistémico y síndrome antifosfolipídicoEntity: Universitat de Barcelona Type of entity: UniversityStudent: Sonia Jiménez HerrnándezDate of reading: 12/2007

6 Project title: Anticuerpos antiprotrombina y resistencia adquirida a la proteína C activada en el síndromeantifosfolipídicoEntity: Universitat de Barcelona Type of entity: UniversityStudent: Francisco José Muñoz RodríguezDate of reading: 12/2003

7 Project title: Anticuerpos anti-ß2-glicoproteína I en paciente con síndrome de los anticuerpos antifosfolipídicosEntity: Universitat de Barcelona Type of entity: UniversityStudent: Montserrat Teixidó ColetDate of reading: 07/1997

8 Project title: Análisis pronóstico de los pacientes afectos de Síndrome de Inmunodeficiencia Adquirida en elHospital Universitario "Germans Trias i Pujol" de Badalona.Entity: Universitat Autònoma de Barcelona Type of entity: UniversityStudent: Guillermo Sirera JiménezDate of reading: 03/1993

ce46abfe1b997dc092066835783957ac

8

Scientific and technological experience

Scientific or technological activities

R&D projects funded through competitive calls of public or private entities

1 Name of the project: IDENTIFICACIÓN DE NUEVOS MECANISMOS DE REGULACIÓN DE LAHEMOSTASIA: CONTROL DE LA FUNCIÓN PLAQUETARIA A TRAVÉS DE LA PROTEÍNA CPEB4Entity where project took place: Consejo Superiorde Investigaciones Científicas

Type of entity: State agency

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): P Navarro; P García de Frutos; D Tàssies; JC ReverterFunding entity or bodies:Fundación Española de Trombosis y Hemostasia Type of entity: FoundationCity funding entity: Madrid, Spain

Code according to the funding entity: Beca López Borrasca 2017Start-End date: 01/2018 - 01/2020Total amount: 15.000 €

2 Name of the project: CANCER Y TROMBOEMBOLISMO: IMPORTANCIA DE LA GENERACIÓN DETROMBINA RELACIONADA CON LAS MICROPARTICULAS PROCOAGULANTES CIRCULANTES Y LOSPOLIMORFISMOS DE LAS MISMAS EN EL DESARROLLO DE TROMBOSIS EN LOS PACIENTES CONCANCEREntity where project took place: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

Code according to the funding entity: FIS 07/0387Start-End date: 01/2008 - 12/2010Total amount: 106.480 €

3 Name of the project: TROMBOSIS ASOCIADAS AL CÁNCER: IMPORTANCIA DE LOSPOLIMORFISMOS GENÉTICOS RELACIONADOS CON LA ADHESIÓN Y FUNCIÓN PROCOAGULANTEDE LAS MICROPARTÍCULAS Y DE LA TROMBINA GENERADA DURANTE LA FORMACIÓN DELCOÁGULOEntity where project took place: Hospital Clínic deBarcelona

Type of entity: Healthcare Institutions

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:FEHH - Fundación Española de Trombosis yHemostasia.

Type of entity: Foundation

Code according to the funding entity: Beca FEHH para proyectos de investigación Básica o Clínica -2005

ce46abfe1b997dc092066835783957ac

9

Start-End date: 10/2005 - 10/2006Total amount: 12.000 €

4 Name of the project: GENERACION DE TROMBINA DURANTE EL MECANISMO DE FORMACION DELCOAGULO EN EL SINDROME ANTI-FOSFOLIPIDICO. ESTUDIO DE LOS FACTORES DETERMINANTESY RELACION CON LAS MANIFESTACIONES CLINICASEntity where project took place: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

Code according to the funding entity: FIS 02/ 0696Start-End date: 10/2002 - 10/2005Total amount: 55.200 €

5 Name of the project: EFECTO DE LOS ANTICUERPOS ANTIFOSFOLIPIDO EN LA ACTIVACION DELCOMPLEJO DE CONTACTO DE LA VIA INTRINSECA DE LA COAGULACION: IMPORTANCIA EN ELDESARROLLO DE TROMBOSIS EN EL SINDROME ANTIFOSFOLIPIDOEntity where project took place: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

Code according to the funding entity: FIS 99/ 0148Start-End date: 01/1999 - 12/2000

6 Name of the project: EFECTO DE LOS ANTICUERPOS ANTIFOSFOLIPIDO EN EL RECLUTAMIENTODE CAPAS SUCESIVAS DE PLAQUETAS Y SU INTERFERENCIA EN LA INACTIVACION DESUPERFICIES TROMBOGENICAS. IMPORTANCIA EN LA PATOFISIOLOGIA DEL SINDROMEANTIFOSFOLIPIDO.Entity where project took place: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

Name principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

Code according to the funding entity: FIS 95/ 0250Start-End date: 01/1995 - 12/1996

7 Name of the project: EFECTO DEL RECEPTOR DE TROMBINA EN LA FISIOPATOLOGIA DE LASENFERMEDADES TROMBOTICASEntity where project took place: Mount Sinai Hospital. City University of New York.City of entity: Nueva York, United States of AmericaName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

ce46abfe1b997dc092066835783957ac

10

Start-End date: 01/1994 - 01/1995

8 Name of the project: IMPLICACION DE LOS ANTICUERPOS ANTIFOSFOLIPIDO EN LA TROMBOSIS:ESTUDIO DE SU ACCION SOBRE LAS PLAQUETAS Y LA FORMACION DE TROMBINA.Entity where project took place: Hospital Clinic deBarcelona

Type of entity: Healthcare Institutions

City of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Instituto de Salud Carlos III Type of entity: Public Research BodyCity funding entity: Majadahonda, Community of Madrid, Spain

Code according to the funding entity: FIS 92/ 0782Start-End date: 01/1992 - 12/1992

9 Name of the project: OBTENCIÖN DE UN MODELO MATEMATICO PARA LA PREDICCIÓN DE DEEXTENSION ABDOMINAL DE LA ENFERMEDAD DE HODGKINEntity where project took place: Hospital Clínic de BarcelonaCity of entity: Barcelona, Catalonia, SpainName principal investigator (PI, Co-PI....): Juan Carlos Reverter CalatayudFunding entity or bodies:Generalitat de Catalunya Type of entity: Comisión Interdepartamental de

InvestigaciónCity funding entity: Barcelona, Catalonia, Spain

Code according to the funding entity: CIRIT AR 85-189Start-End date: 12/1985 - 12/1986

Scientific and technological activities

Scientific production

H index: 46Date of application: 14/10/2020Fuente de Indice H: SCOPUS

Publications, scientific and technical documents

1 Congenital antithrombin deficiency in patients with splanchnic vein thrombosis. Liver Int. 40 - 5, pp. 1168 - 1177.2020.Type of production: Scientific paper Format: Journal

2 High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?. J ThrombThrombolysis. Jul 15, pp. 1 - 5. 2020.Type of production: Scientific paper Format: Journal

3 In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients onanticoagulation. J Thromb Haemost. Aug 6, pp. 1111/jth.15043. doi: 10.1111/jth.15043. 2020.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

11

4 Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center. Lupus. Aug 29, pp.1050 - 1059. 2020.Type of production: Scientific paper Format: Journal

5 Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus. JThromb Thrombolysis. Aug 29, pp. DOI: 10.1007/s11239-020-02295-1_. 2020.Type of production: Scientific paper Format: Journal

6 Study of Biocompatibility of Membranes in Online Hemodiafiltration. Blood Purif. 49 - 2, pp. 400 - 408. 2020.Type of production: Scientific paper Format: Journal

7 J Munrós; D Tàssies; JC Reverter; L Martín; A Pérez; F Carmona; MA Martínez-Zamora. Circulating NeutrophilExtracellular Traps Are Elevated in Patients With Deep Infiltrating Endometriosis. Reprod Sci. 26, pp. 70 - 76.2019.Type of production: Scientific paper Format: JournalPosition of signature: 3Total no. authors: 7

8 Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma. MethodsMol Biol. 1955 - 2, pp. 275 - 286. 2019.Type of production: Scientific paper Format: Journal

9 Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency.Thromb Haemost. 119 - 2, pp. 1409 - 1418. 2019.Type of production: Scientific paper Format: Journal

10 Study of the analytical performance at different concentrations of hematological parameters using Spanish EQASdata. Clin Chem Lab Med. 57 - 12, pp. 1980 - 1987. 2019.Type of production: Scientific paper Format: Journal

11 J Munrós; MA Martínez-Zamora; D Tàssies; JC Reverter; M Rius; M Gracia; C Ros; F Carmona. TotalCirculating Microparticle Levels After Laparoscopic Surgical Treatment for Endometrioma: A Pilot, Prospective,Randomized Study Comparing Stripping with CO2 Laser Vaporization.J Minim Invasive Gynecol. pp. DOI:https://doi.org/10.1016/j.jmig.201. 2019.Type of production: Scientific paperPosition of signature: 4Total no. authors: 8

12 A Blasi; A Calvo; V Prado; E Reverter; JC Reverter; M Hernández-Tejero; F Aziz; A Amorós; A Cárdenas; JFernández. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis:Beyond the International Normalized Ratio. Hepatology. 68, pp. 2325 - 2337. 2018.Type of production: Scientific paperPosition of signature: 5Total no. authors: 10

13 JP Salvador; MD Tàssies; JC Reverter; MP Marco. Enzyme-linked immunosorbent assays for therapeutic drugmonitoring coumarin oral anticoagulants in plasma.Anal Chim Acta. 1028, pp. 59 - 65. 2018.Type of production: Scientific paper Format: JournalPosition of signature: 3Total no. authors: 4

ce46abfe1b997dc092066835783957ac

12

14 JD Olson; C Bon; P Meijer; I Jennings; R Bonar; EJ Favaloro; RA Higgins; M Keeney; J Mammen; RA Marlar;R Meley; SC Nair; WL Nichols; A Raby; JC Reverter; A Srivastava; I Walker. Lack of grading agreement amonginternational hemostasis external quality assessment programs.Blood Coagul Fibrinolysis.29 - 1, pp. 111 - 119.2018.Type of production: Scientific paper Format: JournalPosition of signature: 15Total no. authors: 17

15 A Molina; L Guiñón; A. Pérez; A. Segurana; JL Bedini; JC Reverter; A Merino. State of the art vs biologicalvariability: Comparison on hematology parameters using Spanish EQAS data.Int J Lab Hematol.40, pp. 284 - 291.2018.Type of production: Scientific paper Format: JournalPosition of signature: 6Total no. authors: 7

16 MA Plasin-Rodriguez; I Rodríguez-Pintó; P Patricio; J Monteagudo; R Cervera; JC Reverter; G Espinosa; DTàssies. The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients withantiphospholipid syndrome.Thromb Res.169, pp. 128 - 134. 2018.Type of production: Scientific paper Format: JournalPosition of signature: 7Total no. authors: 8

17 A Blasi; JC Reverter. Time to change the classical vision of coagulation in liver disease: From the balancedisequilibrium to systems biology network modeling. Minerva Anestesiol.84, pp. 848 - 857. 2018.Type of production: Scientific paper Format: JournalPosition of signature: 2Total no. authors: 2

18 Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: aproof-of-concept, randomised, placebo-controlled trial. Lancet Infect Dis. Apr 18, pp. 419 - 430. 2018.Type of production: Scientific paper Format: Journal

19 F Torrico; J Gascón; L Ortiz; C Alonso-Vega; MJ Pinazo; A Schijman; E1224 Study Group. Treatment of adultchronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept,randomised, placebo-controlled trial.Lancet Infect Dis. 18, pp. 419 - 430. 2018.Type of production: Scientific paper Format: Journal

20 P Olivera; M Gabiliondo; M Constans; D Tàssies; E Plensa; V Pons; G Las Heras; C Jiménez; D Campoy; ABustins; A Oliver; C Marzo; T Canals; A Varela; M Sorigué; E Sánchez; G Ene; G Perea; M Vicente; M López; MCerdà; E Johansson; MR Aguinaco; N Santos; J Mateo; JC Reverter; A Moya; A Santamaría. Tromboc@t WorkingGroup recommendations for management in patients receiving direct oral anticoagulants.[Recomendacionesdel Grupo Catalán de Trombosis (Tromboc@t Working Group) para el tratamiento de los pacientes que recibenanticoagulantes orales directos]. Med Clin (Barc). 210, pp. e1 - e13. 2018.Type of production: Scientific paperPosition of signature: 26Total no. authors: 28

21 Venous Thrombotic Events After Liver Transplantation. Clin Appl Thromb Hemost. 24 - 2, pp. 317 - 322. 2018.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

13

22 L Pujadas-Mestres; I Lopez-Vilchez; E Arellano-Rodrigo; JC Reverter; A Lopez-Farre; M Diaz-Ricart;JJ Badimon; G Escolar. Differential inhibitory action of apixaban on platelet and fibrin components offorming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.PLoS ONE. 12, 2017. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012164046&doi=10.1371%2fjournal.pone.0171486&partnerID=40&md5=e41d5316bbd9e13e773cf9d2fc4f13ae>.Type of production: Scientific paper Format: JournalPosition of signature: 4Total no. authors: 8

23 M Vilaseca; H García-Calderó; E Lafoz; O García-Irigoyen; MA Avila; JC Reverter; J Bosch; V Hernández-Gea; JGracia-Sancho; JC García-Pagán. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainlyby deactivating hepatic stellate cells.Hepatology. 65, pp. 2031 - 2044. 2017. ISSN 1527-3350Type of production: Scientific paperPosition of signature: 6Total no. authors: 10

24 J Munrós; MA Martínez-Zamora; D Tàssies; JL Coloma; MA Torrente; JC Reverter; F Carmona;J Balasch. Total circulating microparticle levels are increased in patients with deep infiltratingendometriosis. Human Reproduction. 32 - 2, pp. 325 - 331. 2017. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014476760&doi=10.1093%2fhumrep%2fdew319&partnerID=40&md5=e56517a7b052825922f21efbc52926ed>.Type of production: Scientific paper Format: JournalPosition of signature: 6Total no. authors: 8

25 MJ Pinazo; EDJ Posada; L Izquierdo; D Tassies; AF Marques; E de Lazzari; E Aldasoro; J Muñoz; AAbras; S Tebar; M Gallego; IC de Almeida; JC Reverter; J Gascon. Altered Hypercoagulability Factors inPatients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response. PLoS NeglectedTropical Diseases. 10, 2016. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969443690&doi=10.1371%2fjournal.pntd.0004269&partnerID=40&md5=905fa59401d90fd5065154d79938f64e>.Type of production: Scientific paper Format: JournalPosition of signature: 13Total no. authors: 14

26 F Cerini; M Vilaseca; E Lafoz; O García-Irigoyen; H García-Calderó; DM Tripathi; M Avila; JC Reverter; J Bosch; JGracia-Sancho; JC García-Pagán. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhoticrats. J Hepatol. 64, pp. 834 - 842. 2016. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84955507528&partnerID=40&md5=3346435e7940cae3bf386de5e41dd86a>.Type of production: Scientific paper Format: JournalPosition of signature: 8Total no. authors: 11

27 MA Martínez-Zamora; D Tàssies; M Creus; JC Reverter; B Puerto; J Monteagudo; F Carmona; J Balasch. Higherlevels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipidantibodies. Human Reproduction. 31, pp. 46 - 52. 2016. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84957606125&partnerID=40&md5=52f64a175cc7304ddd2f382e86b82734>.Type of production: Scientific paper Format: JournalPosition of signature: 4Total no. authors: 8

28 R Montes; E Guruceaga; JR González-Porras; JC Reverter; P Marco; E Pina; JA Páramo; JHermida; R Lecumberri. Identification of new markers of recurrence in patients with unprovokeddeep vein thrombosis by gene expression profiling: The retro study. Eur J Haematol. 97,

ce46abfe1b997dc092066835783957ac

14

pp. 129 - 136. 2016. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84949575576&partnerID=40&md5=cc3e95ac1f39fb420bb7b3ee99f31beb>.Type of production: Scientific paper Format: JournalPosition of signature: 4Total no. authors: 9

29 MA Martínez-Zamora; D Tàssies; JC Reverter; M Creus; G Casals; S Cívico; F Carmona; JBalasch. Increased circulating cell-derived microparticle count is associated with recurrentimplantation failure after IVF and embryo transfer. Reprod BioMed Online. 33, pp. 168- 173. 2016. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969731117&doi=10.1016%2fj.rbmo.2016.05.005&partnerID=40&md5=7ad08a02b27369522cc7ca61831e2e5b>.Type of production: Scientific paper Format: JournalPosition of signature: 3Total no. authors: 8

30 JC Mejía; T Ortiz; D Tàssies; X Solanich; A Vidaller; R Cervera; JC Reverter; G Espinosa.Procoagulant microparticles are increased in patients with Behçet’s disease but do notdefine a specific subset of clinical manifestations. Clinical Rheumatology. 35, pp. 695- 699. 2016. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960368110&doi=10.1007%2fs10067-015-2903-4&partnerID=40&md5=0a84d5ec72a2709d35eceabaf85de177>.Type of production: Scientific paper Format: JournalPosition of signature: 7Total no. authors: 8

31 A Blasi; V Hernandez-Gea; JC Reverter; JC Garcia-Pagán. Reply - Impact of anticoagulationon upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study.Hepatology.64, pp. 321 - 322. 2016. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976498982&doi=10.1002%2fhep.28371&partnerID=40&md5=fb2487b49a39738c1209caa01c391c8c>.Type of production: Scientific paper Format: JournalPosition of signature: 3Total no. authors: 4

32 A Blasi; V Hernandez; J Fernandez; J Colmenero; J Beltran; JC Garcia Valdecasas; JC Reverter. VenousThrombotic Events After Liver Transplantation.Clin Appl Thromb Hemost. 24, pp. 317 - 322. 2016. ISSN1938-2723Type of production: Scientific paperPosition of signature: 8Total no. authors: 8

33 J Aibar; P Castro; G Espinosa; S Fernández; C Hernández; M Rinaudo; M Butjosa;D Tàssies; JC Reverter; JM Nicolás. ADAMTS-13 in Critically Ill Patients with SepticSyndromes and Noninfectious Systemic Inflammatory Response Syndrome. Shock. 43, pp.556 - 562. 2015. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942851940&doi=10.1097%2fSHK.0000000000000341&partnerID=40&md5=db035354fa9a40f349de4096eb48d3c9>.Type of production: Scientific paper Format: JournalPosition of signature: 9Total no. authors: 10

34 E Arellano-Rodrigo; I Lopez-Vilchez; AM Galan; P Molina; JC Reverter; X Carné; J Villalta;D Tassies; M Lozano; M Díaz-Ricart; G Escolar. Coagulation Factor Concentrates Fail toRestore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in StudiesWith Flowing Blood From Treated Healthy Volunteers. Transfusion Medicine Reviews. 29,

ce46abfe1b997dc092066835783957ac

15

pp. 242 - 249. 2015. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941944181&doi=10.1016%2fj.tmrv.2015.08.001&partnerID=40&md5=cafa89791bb6619897f628372186b13a>.Type of production: Scientific paper Format: JournalPosition of signature: 5Total no. authors: 11

35 S Martin-Rodriguez; JC Reverter; D Tàssies; G Espinosa; M Heras; M Pino; G Escolar; M Diaz-Ricart.Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus. Lupus.24, pp. 1143 - 1149. 2015. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941219770&doi=10.1177%2f0961203315579091&partnerID=40&md5=0816f19ceaf1c7e1bb8265f1a9f17421>.Type of production: Scientific paper Format: JournalPosition of signature: 2Total no. authors: 8

36 G Escolar; E Arellano-Rodrigo; I Lopez-Vilchez; P Molina; J Sanchis; JC Reverter; X Carne; J Cid; J Villalta;D Tassies; AM Galan; M Diaz-Ricart. Reversal of rivaroxaban-induced alterations on hemostasis by differentcoagulation factor concentrates – In vitro studies with steady and circulating human blood. CirculationJournal. 79, pp. 331 - 338. 2015. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928254284&doi=10.1253%2fcircj.CJ-14-0909&partnerID=40&md5=1a82b16959d45353eb0a5da7923107f7>.Type of production: Scientific paper Format: JournalPosition of signature: 6Total no. authors: 12

37 MA Martínez-Zamora; D Tàssies; JC Reverter; J Balasch; F Carmona. Risk Factors for Changes of FibrinolysisDuring Benign Adnexal Laparoscopic Surgery.J Minim Invasive Gynecol. 22 - 6S, pp. S161. 2015. ISSN1553-4669Type of production: Scientific paperPosition of signature: 3Total no. authors: 5

38 O Escoda-Turon; C Martín-Sierra; JC Reverter; S Nogué-Xarau. Coagulation disorder after abite from Vipera latastei [Coagulopatía asociada a mordedura de Vipera latastei]. Emergencias.26, pp. 416 - 417. 2014. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925983409&partnerID=40&md5=9b502309e8ffafaefb1d794119be8fb2>.Type of production: Scientific paper Format: JournalPosition of signature: 3Total no. authors: 4

39 P Recarte-Pelz; D Tàssies; G Espinosa; B Hurtado; N Sala; R Cervera; JC Reverter; P Garcia de Frutos.Correction: Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupuserythematosus: Correlation with common genetic variants and disease activity [Arthritis Res Ther, 15, (2013) R41.].Arthritis Research and Therapy. 16, 2014. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84893840127&partnerID=40&md5=e2a511a0254cb789eaf956ae841abf8f>.Type of production: Scientific paper Format: Journal

40 JC Mejía; G Espinosa; D Tàssies; JC Reverter; R Cervera. Endogenous thrombin potential inBehçet's disease: Relationship with thrombosis and anticoagulant therapy. Clin Exp Rheumatol.32, pp. S67 - S71. 2014. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907483781&partnerID=40&md5=c6a5311cbff328476f902f446a7c5073>.Type of production: Scientific paper Format: JournalPosition of signature: 4Total no. authors: 5

ce46abfe1b997dc092066835783957ac

16

41 S. Saibeni; M.J. Etchevers; D. Tassies; J. Panés; J.C. Reverter; S. Danese; J.M. Piqué; S. Bruno;M. Vecchi; A. Gasbarrini; M. Sans. Assessment of anti-prothrombin antibodies in thrombosiscomplicating inflammatory bowel diseases. International Journal of Colorectal Disease. 28 - 9,pp. 1281 - 1286. 2013. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883284206&doi=10.1007%2fs00384-013-1696-7&partnerID=40&md5=30d2e4bbede0d07156da69e8d4bd8c6e>.Type of production: Scientific paper Format: Journal

42 M. Sánchez; G. Escolar; J.C. Reverter. Bleeding in patients on anticoagulant therapy: The real utility of antidotesand how to manage bleeding in patients on new-generation oral anticoagulants [Hemorragias en pacientesanticoagulados: Utilidad real de los antídotos y modo de actuación con los nuevos anticoagulantes orales].Emergencias. 25 - 6, pp. 482 - 490. 2013. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900295651&partnerID=40&md5=b71f2be520d5f378b1315d6faee48e7f>.Type of production: Scientific paper Format: Journal

43 H. Berman; M.F. Ugarte Gil; G. Espinosa; D. Tàssies; J. Monteagudo; J.C. Reverter; R. Cervera. Can inheritedthrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?. Clinical andExperimental Rheumatology. 31 - 6, pp. 926 - 932. 2013. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84892468824&partnerID=40&md5=c227711b9c39acdd8cd9b4e22ec69b97>.Type of production: Scientific paper Format: Journal

44 J.A. Gómez Puerta; P. Peris; J.C. Reverter; G. Espinosa; A. Martinez Ferrer; A. Monegal; J.Monteagudo; D. Tàssies; N. Guañabens. High prevalence of prothrombotic abnormalities in multifocalosteonecrosis: Description of a series and review of the literature. Medicine (United States). 92- 6, pp. 295 - 304. 2013. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84887850835&partnerID=40&md5=b0dbdf907893d2b11a4f3fce197496e9>.Type of production: Scientific paper Format: Journal

45 G. Escolar; V. Fernandez-Gallego; E. Arellano-Rodrigo; J. Roquer; J.C. Reverter; V.V. Sanz; P. Molina;I. Lopez-Vilchez; M. Diaz-Ricart; A.M. Galan. Reversal of apixaban induced alterations in hemostasisby different coagulation factor concentrates: Significance of studies In Vitro with circulating humanblood. PLoS ONE. 8 - 11, 2013. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892921288&doi=10.1371%2fjournal.pone.0078696&partnerID=40&md5=e71459ffbbdf0243872f8d8570ce08d1>.Type of production: Scientific paper Format: Journal

46 J.R. González-Juanatey; J.M. Lobos; J.C. Reverter; V. Becerra. Self-management of vitaminK antagonists is more cost-effective than dabigatran for stroke prevention in non-valvularatrial fibrillation in Spain. Response. Revista española de cardiología (English ed.). 66 - 6,pp. 511 - 511. 2013. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929938545&doi=10.1016%2fj.rec.2012.12.004&partnerID=40&md5=af12bb79a1812eda8ce3d0f0a4956097>.Type of production: Scientific paper Format: Journal

47 J.R. González Juanatey; J.M. Lobos; J.C. Reverter; V. Becerra. Self-management of vitamin k antagonistsis more cost-effective than dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.Response [El autocontrol de la terapia con cumarínicos es más eficiente que dabigatrán para prevenirictus en fibrilación auricular no valvular en España. Respuesta]. Revista Espanola de Cardiologia.66 - 6, pp. 511 - 511. 2013. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84878250796&partnerID=40&md5=6ee176a6181684cd665ac52b574d0428>.Type of production: Scientific paper Format: Journal

48 P. Recarte Pelz; D. Tàssies; G. Espinosa; B. Hurtado; N. Sala; R. Cervera; J.C. Reverter; P.G. de Frutos.Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupuserythematosus: Correlation with common genetic variants and disease activity. Arthritis Research andTherapy. 15 - 2, pp. R41. 2013. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84874792957&partnerID=40&md5=daff11033aec8110006a257363796776>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

17

49 E. Arellano Rodrigo; A. Alvarez Larrán; J.C. Reverter; N. Villamor; J.M. Jou; F. Cervantes. Automatedassessment of the neutrophil and platelet activation status in patients with essential thrombocythemia.Platelets. 23 - 5, pp. 336 - 343. 2012. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84863713286&partnerID=40&md5=bc899311be8bae31536b5ccf205064eb>.Type of production: Scientific paper Format: Journal

50 J.R. González Juanatey; J. Álvarez Sabin; J.M. Lobos; A. Martínez Rubio; J.C. Reverter; I. Oyagüez;N. González Rojas; V. Becerra. Cost-effectiveness of dabigatran for stroke prevention in non-valvularatrial fibrillation in Spain [Análisis coste-efectividad de dabigatrán para la prevención de ictus yembolia sistémica en fibrilación auricular no valvular en España]. Revista Espanola de Cardiologia.65 - 10, pp. 901 - 910. 2012. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84867012453&partnerID=40&md5=36eebbf782915d43d97ac885c207355b>.Type of production: Scientific paper Format: Journal

51 S. Raffa; J.C. Reverter; S. Seijo; D. Tassies; J.G. Abraldes; J. Bosch; J.C. García-Pagán. Hypercoagulabilityin patients with chronic noncirrhotic portal vein thrombosis. Clinical Gastroenterology and Hepatology.10 - 1, pp. 72 - 78. 2012. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-83755224861&doi=10.1016%2fj.cgh.2011.09.010&partnerID=40&md5=6556da900440897f9e022a3f9188d556>.Type of production: Scientific paper Format: Journal

52 F. Ballesteros; D. Tassies; J.C. Reverter; I. Alobid; M. Bernal Sprekelsen. Idiopathic sudden sensorineuralhearing loss: Classic cardiovascular and new genetic risk factors. Audiology and Neurotology. 17- 6, pp. 400 - 408. 2012. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-84865613361&partnerID=40&md5=d9599ead08c93c5b1e442bd9b35bd56a>.Type of production: Scientific paper Format: Journal

53 J.L. Reverter; D. Tssies; N. Alonso; S. Pellitero; A. Sanmartí; J.C. Reverter. Non-detectableChlamydophila pneumoniae DNA in peripheral leukocytes in type 2 diabetes mellituspatients with and without carotid atherosclerosis. Medicina Clinica. 138 - 1, pp. 11- 14. 2012. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855792175&doi=10.1016%2fj.medcli.2011.02.029&partnerID=40&md5=fbfa896d097c9ddd225f7ed91404546c>.Type of production: Scientific paper Format: Journal

54 M.A. Martinez-Zamora; S. Peralta; M. Creus; D. Tassies; J.C. Reverter; G. Espinosa; R. Cervera;F. Carmona; J. Balasch. Risk of thromboembolic events after recurrent spontaneous abortionin antiphospholipid syndrome: A case-control study. Annals of the Rheumatic Diseases. 71 -1, pp. 61 - 66. 2012. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-82955214541&doi=10.1136%2fard.2011.153817&partnerID=40&md5=2165ec61687e543f792041fbb16ddc94>.Type of production: Scientific paper Format: Journal

55 M. Roqué; M. Sitges; J. Sala; V. Delgado; M. Morales; J. Marrugat; J. Vila; I. Subirana; D.Tàssies; J.C. Reverter; M. Castro; M. Duran. Effects of raloxifene on endothelial function andhemostasis in women with ischemic heart disease [Efecto del raloxifeno en la función endotelialy la hemostasia en mujeres con enfermedad coronaria]. Revista Espanola de Cardiologia. 64 -7, pp. 572 - 578. 2011. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959376409&doi=10.1016%2fj.recesp.2011.03.005&partnerID=40&md5=4eb7b0e7e401a2e10b700d7c8dbe6124>.Type of production: Scientific paper Format: Journal

56 M. Pinazo; D. Tassies; J. Muñoz; R. Fisa; E. de Jesús; J. Monteagudo; E. Ayala; M. Gállego; J.-C. Reverter; J.Gascon. Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients. Thrombosis and Haemostasis.106 - 4, pp. 617 - 623. 2011. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053186374&doi=10.1160%2fTH11-04-0251&partnerID=40&md5=eed8d483ba15728dec1fe43072595125>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

18

57 C. Font; B. Farrús; L. Vidal; T.M. Caralt; L. Visa; B. Mellado; D. Tàssies; J. Monteagudo; J.C. Reverter;P. Gascon. Incidental versus symptomatic venous thrombosis in cancer: A prospective observationalstudy of 340 consecutive patients. Annals of Oncology. 22 - 9, pp. 2101 - 2106. 2011. Available on-lineat: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052415741&doi=10.1093%2fannonc%2fmdq720&partnerID=40&md5=301dc593f07b3af7c0de3dec9383ff3f>.Type of production: Scientific paper Format: Journal

58 M.A. Martnez Zamora; M. Creus; D. Tassies; J.C. Reverter; S. Civico; F. Carmona; J. Balasch. Reducedplasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer. HumanReproduction. 26 - 3, pp. 510 - 516. 2011. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-79951564332&partnerID=40&md5=cd92c24d6ecb04ce9b3781bdd02aadf6>.Type of production: Scientific paper Format: Journal

59 E. Guasch; A. Sionis; J.C. Reverter; R. Andrea; P. Loma Osorio; X. Freixa; M. Heras. Safetyissues of adjunctive clopidogrel in patients discharged after percutaneous coronary interventionwith stent placement and requiring oral anticoagulation. International Journal of Cardiology. 146- 1, pp. e1 - e4. 2011. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-78650843790&partnerID=40&md5=cca55df71131367cc39af80bf872cdf4>.Type of production: Scientific paper Format: Journal

60 C. Font; L. Vidal; G. Espinosa; D. Tàssies; J. Monteagudo; B. Farrús; L. Visa; R. Cervera; P. Gascon;J.C. Reverter. Solid cancer, antiphospholipid antibodies, and venous thromboembolism. AutoimmunityReviews. 10 - 4, pp. 222 - 227. 2011. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951850402&doi=10.1016%2fj.autrev.2010.10.006&partnerID=40&md5=1629af85e23b3c412c5b8af886b21b58>.Type of production: Scientific paper Format: Journal

61 V. La Mura; J.C. Reverter; A. Flores Arroyo; S. Raffa; E. Reverter; S. Seijo; J.G. Abraldes; J. Bosch; J.C. GarcíaPagán. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.Gut. 60 - 8, pp. 1133 - 1138. 2011. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-79960322140&partnerID=40&md5=9cf075da8d204262a87a29e17c4af513>.Type of production: Scientific paper Format: Journal

62 M.A. Martínez Zamora; D. Tassies; F. Carmona; G. Espinosa; R. Cervera; J.C. Reverter; J.Balasch. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsiawith or without associated antiphospholipid antibodies. Journal of Reproductive Immunology. 86- 2, pp. 133 - 140. 2010. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-77957252571&partnerID=40&md5=38d1dd772bec0aef3c9e44d003416ccb>.Type of production: Scientific paper Format: Journal

63 D. Tàssies; J.-C. Reverter. Hematologic abnormalities in the antiphospholipid syndrome. Current RheumatologyReviews. 6 - 1, pp. 55 - 63. 2010. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950251616&partnerID=40&md5=f558e63810ddd727262f48412587c6e2>.Type of production: Scientific paper Format: Journal

64 S. Pellitero; J.L. Reverter; D. Tàssies; E. Pizarro; J. Monteagudo; I. Salinas; E. Aguilera; A. Sanmartí;J.C. Reverter. Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterialthrombosis and carotid atherosclerosis in type 2 diabetes. Thrombosis and Haemostasis. 103 -3, pp. 630 - 637. 2010. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-77749298342&doi=10.1160%2fTH09-07-0453&partnerID=40&md5=be468279f7e91566662696448fd80786>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

19

65 M. Basora; G. Fita; P. Panigua; H. Litvan; A. Fló; J.C. Reverter. Survey of perioperative hemostasis andtransfusion management in cardiac surgery: how do anesthesiologists practice? [Encuesta de hemostasiay transfusión perioperatoria en cirugía cardiaca: cómo actuamos los anestesólogos?]. Revista española deanestesiología y reanimación. 57 - 1, pp. 3 - 10. 2010. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951243459&partnerID=40&md5=ecf255595f3e5430880c3d12e634ce61>.Type of production: Scientific paper Format: Journal

66 M.A. Martínez Zamora; M. Creus; D. Tassies; A. Bové; J.C. Reverter; F. Carmona; J.Balasch. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrentmiscarriage associated with the antiphospholipid syndrome. Fertility and Sterility. 94 - 6, pp.2437 - 2440. 2010. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-78049265797&partnerID=40&md5=7729c98cc6bd147c8bf0624b0f89d771>.Type of production: Scientific paper Format: Journal

67 I. Lázaro; F. Carmona; J.C. Reverter; R. Cervera; D. Tassies; J. Balasch. Antiphospholipid antibodies mayimpair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelialcells in culture and monoclonal anticardiolipin antibodies. American Journal of Obstetrics and Gynecology.201 - 1, pp. 87.e1 - 87.e6. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-67649502333&partnerID=40&md5=b028f9dd02a4863d8a1ead8af9f3e316>.Type of production: Scientific paper Format: Journal

68 S. Pellitero; J.L. Reverter; M.L. Granada; E. Pizarro; C.M. Pastor; D. Tàssies; J.C. Reverter; I.Salinas; A. Sanmarti. Association of the IGF1/pregnancy-associated plasma protein - A systemand adipocytokine levels with the presence and the morphology of carotid plaques in type 2diabetes mellitus patients with stable glycaemic control. European Journal of Endocrinology. 160- 6, pp. 925 - 932. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-66149120181&doi=10.1530%2fEJE-09-0097&partnerID=40&md5=213bf2e66b1233d8ae0eaae2848a2cca>.Type of production: Scientific paper Format: Journal

69 J.C. Reverter; M.D. Tàssies. Chapter 7 Genetic Aspects of the Antiphospholipid Syndrome:Association with Clinical Manifestations. Handbook of Systemic Autoimmune Diseases. 10,pp. 91 - 103. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649666531&doi=10.1016%2fS1571-5078%2808%2900407-8&partnerID=40&md5=37408938f43d82e8f6d088da41a69624>.Type of production: Scientific paper Format: Journal

70 R. Cervera; G. Espinosa; J.C. Reverter. Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome.Handbook of Systemic Autoimmune Diseases. 10, pp. 105 - 116. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649644225&doi=10.1016%2fS1571-5078%2808%2900408-X&partnerID=40&md5=d89439674809fb36b0bcb053bb4c896f>.Type of production: Scientific paper Format: Journal

71 G. De La Red; D. Tàssies; G. Espinosa; J. Monteagudo; A. Bové; J. Plaza; R. Cervera; J.-C. Reverter.Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patientswith antiphospholipid antibodies and high fibrinogen levels. Thrombosis and Haemostasis. 101 -2, pp. 312 - 316. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-62449126466&doi=10.1160%2fTH08-06-0347&partnerID=40&md5=68f3553b44a40320ea9cfd532023c429>.Type of production: Scientific paper Format: Journal

72 F. Ballesteros; I. Alobid; D. Tassies; J.C. Reverter; R.E. Scharf; J.M. Guilemany; M. Bernal Sprekelsen. Isthere an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?. Audiology andNeurotology. 14 - 3, pp. 139 - 145. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-63449093440&partnerID=40&md5=b5ced10a2371163115763b306d22b0fc>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

20

73 J. Orbe; J.A. Rodríguez; O. Calvayrac; R. Rodríguez-Calvo; C. Rodríguez; C. Roncal; S.M.De Lizarrondo; J. Barrenetxe; J.C. Reverter; J. Martínez-González; J.A. Páramo. Matrixmetalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patientswith enhanced thrombin generation. Arteriosclerosis, Thrombosis, and Vascular Biology. 29 - 12,pp. 2109 - 2116. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-73849152504&doi=10.1161%2fATVBAHA.109.194589&partnerID=40&md5=0e2749cdde54a4e4cbced411face162d>.Type of production: Scientific paper Format: Journal

74 E. Arellano Rodrigo; A. Alvarez Larrán; J.-C. Reverter; D. Colomer; N. Villamor; B. Bellosillo; F. Cervantes.Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essentialthrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden. American Journal ofHematology. 84 - 2, pp. 102 - 108. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-59949089238&partnerID=40&md5=1666a88508b29ef5a206b05df6a13509>.Type of production: Scientific paper Format: Journal

75 D. Rigau Comas; J. Álvarez Sabin; A. Gil Núñez; S. Abilleira Castells; F.X. Borras Pérez; P. Armario García;E. Arrieta Antón; E. Marañón Fernández; J.C. Martí Canales; A. Morales Ortiz; J.C. Reverter Calatayud;E. Sancristóbal Velasco; I. Solà Arnau; P. Alonso Coello. Primary and secondary prevention of stroke: Aguideline [Guía de práctica clínica sobre prevención primaria y secundaria del ictus]. Medicina Clinica.133 - 19, pp. 754 - 762. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-70449527570&partnerID=40&md5=07e9a0b159af6af0280c392b8b5cf6b5>.Type of production: Scientific paper Format: Journal

76 R. Cervera; J.C. Reverter; M.A. Khamashta. Series Editor. Handbook of Systemic AutoimmuneDiseases. 10, pp. ix - x. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-67649647434&partnerID=40&md5=702f9ecf61feb4adedb273b7b373d7d2>.Type of production: Scientific paper Format: Journal

77 M.A. Martinez Zamora; D. Tassies; F. Carmona; G. Espinosa; R. Cervera; J.C. Reverter; J. Balasch.Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipidsyndrome: Relationship with pregnancy outcome and thrombosis. American Journal of ReproductiveImmunology. 62 - 6, pp. 381 - 389. 2009. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-70450197757&partnerID=40&md5=9766305b04656b83aa76e66fdcefe48d>.Type of production: Scientific paper Format: Journal

78 D. Tàssies; M. Roqué; J. Monteagudo; T. Martorell; A. Sionis; D. Arzamendi; M. Heras;J.-C. Reverter. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms asmarkers of the type of acute coronary syndrome. Thrombosis Research. 124 - 5, pp.614 - 618. 2009. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349856157&doi=10.1016%2fj.thromres.2009.07.004&partnerID=40&md5=1e22b39c47bfbca61ef10873a5319af7>.Type of production: Scientific paper Format: Journal

79 M. Rodríguez Carballeira; C. De Juan; J.C. Reverter. Bilateral suprarenal hematoma in a46-year-old male [Varón de 46 años con hematoma suprarrenal bilateral]. Medicina Clinica. 130- 2, pp. 71 - 77. 2008. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-39749172544&doi=10.1157%2f13115030&partnerID=40&md5=ad9cec94dde43a1c471aae2b519369a5>.Type of production: Scientific paper Format: Journal

80 S. Jiménez; D. Tàssies; G. Espinosa; Á. García Criado; J. Plaza; J. Monteagudo; R. Cervera; J.C. Reverter.Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis andarteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Annals of theRheumatic Diseases. 67 - 6, pp. 835 - 840. 2008. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-45149103015&partnerID=40&md5=05bac842d15498e4ed1cf5fedd192e20>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

21

81 G. Gutiérrez; A. Merino; A. Domingo; J.M. Jou; J.C. Reverter. EQAS for peripheral bloodmorphology in Spain: A 6-year experience. International Journal of Laboratory Hematology. 30 -6, pp. 460 - 466. 2008. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-55149122463&doi=10.1111%2fj.1751-553X.2007.00975.x&partnerID=40&md5=94de55bc16a9ad0620da77b6b2b65d16>.Type of production: Scientific paper Format: Journal

82 A. Alvarez Larrán; E. Arellano Rodrigo; J.C. Reverter; A. Domingo; N. Villamor; D. Colomer; F. Cervantes.Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis. Annals of Hematology.87 - 4, pp. 269 - 276. 2008. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-41249088995&partnerID=40&md5=36f369d62626911feaf71d83b364b10c>.Type of production: Scientific paper Format: Journal

83 J.L. Navarro; J.M. César; M.Á. Fernández; J. Fontcuberta; J.C. Reverter; J. Gol Freixas. Oral anticoagulanttreatment: A cost-benefit study [Tratamiento anticoagulante oral. Estudio coste/beneficio]. Revista deAdministracion Sanitaria. 6 - 3, pp. 525 - 542. 2008. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-56849093952&partnerID=40&md5=072976090e152ea80fc2f48fff6cd53e>.Type of production: Scientific paper Format: Journal

84 J. Font; M. Ramos Casals; P. Brito Zerón; N. Nardi; A. Ibañez; B. Suarez; S. Jiménez; D. Tàssies; A. GarcíaCriado; E. Ros; J. Sentís; J.-C. Reverter; F. Lozano. Association of mannose-binding lectin gene polymorphismswith antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupuserythematosus. Rheumatology. 46 - 1, pp. 76 - 80. 2007. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-33845596640&partnerID=40&md5=d3051223a112f7683cde58b154508e35>.Type of production: Scientific paper Format: Journal

85 M. Alvarez Lobos; J.I. Arostegui; M. Sans; D. Tassies; J. Piu; J.C. Reverter; J.M. Pique; J. Yagüe;J. Panés. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotypingpredicts complicated Crohn's disease behaviour. Alimentary Pharmacology and Therapeutics. 25- 4, pp. 429 - 440. 2007. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-33846595225&partnerID=40&md5=6cb960e62d689144d64656d5ef94bbf0>.Type of production: Scientific paper Format: Journal

86 G. García Segarra; G. Espinosa; D. Tassies; J. Oriola; J. Aibar; A. Bové; P. Castro; J.-C.Reverter; J.-M. Nicolás. Increased mortality in septic shock with the 4G/4G genotype ofplasminogen activator inhibitor 1 in patients of white descent. Intensive Care Medicine. 33 - 8,pp. 1354 - 1362. 2007. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-34547100529&partnerID=40&md5=eb3a0df6dbc21eeb5d76a70c23d5ac50>.Type of production: Scientific paper Format: Journal

87 J.L. Navarro Navarro; J.M. Cesar; M.A. Fernández; J. Fontcuberta; J.C. Reverter; J. Gol-Freixa.Morbidity and mortality in patients treated with oral anticoagulants [Morbilidad y mortalidad enpacientes con tratamiento anticoagulante oral]. Revista Espanola de Cardiologia. 60 - 12, pp.1226 - 1232. 2007. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-37349003172&doi=10.1157%2f13113927&partnerID=40&md5=7ed20a764443c18d6f34cf0bc93ffcea>.Type of production: Scientific paper Format: Journal

88 S. Pellitero; J.L. Reverter; E. Pizarro; M.C. Pastor; M.L. Granada; D. Tàssies; J.-C. Reverter;I. Salinas; A. Sanmartí. Pregnancy-associated plasma protein-A levels are related to glycemiccontrol but not to lipid profile or hemostatic parameters in type 2 diabetes. Diabetes Care. 30 - 12,pp. 3083 - 3085. 2007. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-37149045357&doi=10.2337%2fdc07-1092&partnerID=40&md5=7dc3a040cd8d4821d9db389098cac1b4>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

22

89 M.D. Tàssies Penella; J. Monteagudo Terres; J.C. Reverter Calatayud. Role of genetic polymorphism in selectinsand tissue factor in venous thromboembolism in young patients [Importancia de los polimorfismos genéticos deselectinas y factor tisular en la etiopatogenia de la enfermedad tromboembólica venosa en pacientes jóvenes].Mapfre Medicina. 18 - 4, pp. 316 - 322. 2007. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-46849094306&partnerID=40&md5=886f611eb46e1376a7627118bbb25e37>.Type of production: Scientific paper Format: Journal

90 A. Cervera; D. Tàssies; V. Obach; S. Amaro; J.C. Reverter; A. Chamorro. The BC genotypeof the VNTR polymorphism of platelet glycoprotein Ib? is overrepresented in patients withrecurrent stroke regardless of aspirin therapy. Cerebrovascular Diseases. 24 - 2-3, pp.242 - 246. 2007. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548100282&doi=10.1159%2f000104485&partnerID=40&md5=a396aa31eb9d66421b91201468b38176>.Type of production: Scientific paper Format: Journal

91 S. Lethagen; P.A. Kyrle; G. Castaman; S. Haertel; P.M. Mannucci; G. Auerswald; J. Batlle; G.Castaman; P. Collins; É. D'Amico; H. Dasani; A.B. Federici; W. Hassenpflug; C. Heller; F. HernándezNavarro; M. Holmström; J. Ingerslev; D. Keeling; J. Klinge; M. Krause; W. Kreuz; P.A. Kyrle; F. LópezFernández; C.A. Ludlam; P.M. Mannucci; W. Miesbach; J. Monteagudo; E.W. Muntean; C. Négrier; P.Petrini; M.Q. Molina; H. Ramschak; J.-C. Reverter; I. Scharrer; R. Schneppenheim; S. Schulman; J.F.Schved; F. Scognamiglio; A. Siebenhofer; T. Spranger; D. Tàssies; S. Vallin; A.V. Camacho; M.V.D.Prondzinski; V. Weltermann. von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based onpharmacokinetics: A prospective multicenter trial in elective surgery. Journal of Thrombosis and Haemostasis.5 - 7, pp. 1420 - 1430. 2007. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-34250691461&partnerID=40&md5=b2d45332dc79157a2d4cae0af81bb4d8>.Type of production: Scientific paper Format: Journal

92 J.C. Reverter. Abnormal hemostasis tests and bleeding in chronic liver disease:Are they related? Yes. Journal of Thrombosis and Haemostasis. 4 - 4, pp. 717 -720. 2006. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644972151&doi=10.1111%2fj.1538-7836.2006.01887.x&partnerID=40&md5=56b3895d3e9fd12147ffcf18e7ba5b38>.Type of production: Scientific paper Format: Journal

93 F. Carmona; I. Lázaro; J.C. Reverter; D. Tàssies; J. Font; R. Cervera; J. Balasch. Impairedfactor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestationsdeveloping late-pregnancy complications. American Journal of Obstetrics and Gynecology. 194- 2, pp. 457 - 465. 2006. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-31844447748&doi=10.1016%2fj.ajog.2005.08.059&partnerID=40&md5=572402315d65af42349d6b73fd6f2803>.Type of production: Scientific paper Format: Journal

94 E. Arellano Rodrigo; A. Alvarez Larrán; J.C. Reverter; N. Villamor; D. Colomer; F. Cervantes.Increased platelet and leukocyte activation as contributing mechanisms for thrombosis inessential thrombocythemia and correlation with the JAK2 mutational status. Haematologica. 91- 2, pp. 169 - 175. 2006. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-33644501833&partnerID=40&md5=e3e14d64ff5d81ebea4e625936bb9eda>.Type of production: Scientific paper Format: Journal

95 J.C. Reverter. Thromboembolic events and prothrombotic phenomena in Chagas disease [Fenómenostromboembólicos y estado protrombótico en la enfermedad de Chagas]. Enfermedades Emergentes. 8- SUPPL. 1, pp. 25 - 27. 2006. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645019505&partnerID=40&md5=1aebb02ad5b3b3fa10c6211a8052a59f>.Type of production: Scientific paper Format: Journal

96 R.A. Asherson; G. Espinosa; R. Cervera; J.A. Gómez Puerta; J. Musuruana; S. Bucciarelli; M. Ramos Casals; A.L.Martínez González; M. Ingelmo; J.C. Reverter; J. Font; D.A. Triplett. Disseminated intravascular coagulation incatastrophic antiphospholipid syndrome: Clinical and haematological characteristics of 23 patients. Annals of the

ce46abfe1b997dc092066835783957ac

23

Rheumatic Diseases. 64 - 6, pp. 943 - 946. 2005. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-21144442653&partnerID=40&md5=5b928a348f29ba9f31a6e975eae502a7>.Type of production: Scientific paper Format: Journal

97 R.A. Asherson; G. Espinosa; R. Cervera; J.A. Gómez Puerta; J. Musuruana; S. Bucciarelli; M. RamosCasals; A.L. Martinéz González; M. Ingelmo; J.C. Reverter; J. Font; D.A. Triplett. Disseminated intravascularcoagulation in catastrophic antiphospholipid syndrome: Clinical and hematological characteristics of 23 patients.Rheumatologia. 19 - 3, pp. 97 - 102. 2005. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-26844579694&partnerID=40&md5=ffa65d2979ff2daf507f7b306cd1de2c>.Type of production: Scientific paper Format: Journal

98 D. Tàssies; J. Monteagudo; S. Maragall; A. Ordinas; J.C. Reverter. No impact of factor IX Ala-10mutations in acenocoumarol-treated southern Europeans. Blood Coagulation and Fibrinolysis. 16- 8, pp. 563 - 566. 2005. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-27844526599&partnerID=40&md5=da280eeda1f81eab00b71a610b70d03a>.Type of production: Scientific paper Format: Journal

99 S. Jiménez; M.A. García Criado; D. Tàssies; J.C. Reverter; R. Cervera; M.R. Gilabert; D. Zambón; E. Ros; C. Bru;J. Font. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.Rheumatology. 44 - 6, pp. 756 - 761. 2005. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-24944496938&partnerID=40&md5=8fd320c33b7511f7f01188afae3b1701>.Type of production: Scientific paper Format: Journal

100 F. Perez Villa; J. Font; M. Azqueta; G. Espinosa; C. Pare; R. Cervera; J.C. Reverter; M. Ingelmo;G. Sanz. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupuserythematosus: A prospective, long-term, followup study. Arthritis Care and Research. 53 - 3,pp. 460 - 467. 2005. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-20444368056&partnerID=40&md5=9b164abc0c974dcc24ed71081a8fd066>.Type of production: Scientific paper Format: Journal

101 J. Bosch; J.C. Reverter. The coagulopathy of cirrhosis: Myth or reality?. Hepatology. 41 - 3,pp. 434 - 435. 2005. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-14244260492&doi=10.1002%2fhep.20639&partnerID=40&md5=3dfd9b01d528825f90bc2c9e8b3481f7>.Type of production: Scientific paper Format: Journal

102 Á. Chamorro; O. Busse; V. Obach; D. Toni; P. Sandercock; J.C. Reverter; A. Cervera; F.Torres; Á. Dávalos. The rapid anticoagulation prevents ischemic damage study in acutestroke - Final results from the writing committee. Cerebrovascular Diseases. 19 - 6, pp.402 - 404. 2005. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-21344431655&doi=10.1159%2f000086100&partnerID=40&md5=00b8db494acb2cedf2d4da2b13562d38>.Type of production: Scientific paper Format: Journal

103 J.M. Jou; G. Gutierrez; J.C. Reverter. Hematology external quality assessment in Europe.Laboratoryhematology : official publication of the International Society for Laboratory Hematology. 10 - 3,pp. 151 - 152. 2004. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-21644465829&partnerID=40&md5=ccefad6535251744904c4d9c216e18af>.Type of production: Scientific paper Format: Journal

104 A. Alvarez Larrán; J.C. García Pagán; J.G. Abraldes; E. Arellano; J.C. Reverter; J. Bosch; F. Cervantes. IncreasedCD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera.British Journal of Haematology. 124 - 3, pp. 329 - 335. 2004. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-17444444006&partnerID=40&md5=f64b49a02e2b93f796a2a629ead691af>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

24

105 F. Fábregues; D. Tàssies; J.C. Reverter; F. Carmona; A. Ordinas; J. Balasch. Prevalence of thrombophiliain women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertility andSterility. 81 - 4, pp. 989 - 995. 2004. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-17444449201&doi=10.1016%2fj.fertnstert.2003.09.042&partnerID=40&md5=589699a044d2e024de1447e950188f33>.Type of production: Scientific paper Format: Journal

106 Á. Cervera; C. Justicia; J.C. Reverter; A.M. Planas; Á. Chamorro. Steady plasma concentrationof unfractionated heparin reduces infarct volume and prevents inflammatory damage aftertransient focal cerebral ischemia in the rat. Journal of Neuroscience Research. 77 - 4, pp.565 - 572. 2004. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-3442889913&doi=10.1002%2fjnr.20186&partnerID=40&md5=39f0d1a96517e4d4aea145b5b90f6fc3>.Type of production: Scientific paper Format: Journal

107 G. Espinosa; S. Bucciarelli; R. Cervera; M. Lozano; J.-C. Reverter; G. De La Red; V. Gil;M. Ingelmo; J. Font; R.A. Asherson. Thrombotic microangiopathic haemolytic anaemiaand antiphospholipid antibodies. Annals of the Rheumatic Diseases. 63 - 6, pp. 730- 736. 2004. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442701758&doi=10.1136%2fard.2003.007245&partnerID=40&md5=3a06c23656bf9254e78f988df0e74e00>.Type of production: Scientific paper Format: Journal

108 A.-M. Galán; R. Tonda; M. Pino; J.C. Reverter; A. Ordinas; G. Escolar. Increased local procoagulantaction: A mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.Transfusion. 43 - 7, pp. 885 - 892. 2003. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038307225&doi=10.1046%2fj.1537-2995.2003.00427.x&partnerID=40&md5=20d60f5981a8564f9781a6f25a13bac2>.Type of production: Scientific paper Format: Journal

109 F. Navarro-López; A. Francino; A. Serra; M. Enjuto; J.C. Reverter; T. Jimenez de Anta; A. Betriu.Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistentinflammatory/immune mechanism? [Linfocitos T y monocitos activados en la reestenosis coronaria.¿Reflejan la persistencia de un mecanismo inflamatorio?]. Revista Espanola de Cardiologia. 56- 5, pp. 465 - 472. 2003. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-18844481383&doi=10.1157%2f13047011&partnerID=40&md5=d0e8a02a76fcee98ddb3337631c35dd5>.Type of production: Scientific paper Format: Journal

110 G. Espinosa; R. Cervera; J. Font; J.C. Reverter; Y. Shoenfeld. Mechanisms of thrombosis in the antiphospholipidsyndrome. Inmunologia. 22 - 1, pp. 53 - 62. 2003. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-69349102139&partnerID=40&md5=4dea3a0868aa527f1921d832410cc2ec>.Type of production: Scientific paper Format: Journal

111 M. Sans; D. Tàssies; M. Pellisé; G. Espinosa; L. Quintó; J.M. Piqué; J.C. Reverter; J. Panés. The 4G/4Ggenotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinantof penetrating behaviour in patients with Crohn's disease. Alimentary Pharmacology and Therapeutics.17 - 8, pp. 1039 - 1047. 2003. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037692737&doi=10.1046%2fj.1365-2036.2003.01536.x&partnerID=40&md5=30e5ee0ba51e1dcc1a3b2a96a46e879f>.Type of production: Scientific paper Format: Journal

112 E. Abella; E. Feliu; I. Granada; F. Millá; A. Oriol; J.M. Ribera; L. Sánchez Planell; Ll. Berga; J.C.Reverter; C. Rozman. Bone marrow changes in anorexia nervosa are correlated with the amountof weight loss and not with other clinical findings. American Journal of Clinical Pathology. 118 -4, pp. 582 - 588. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-19044377826&partnerID=40&md5=72405440cc039d5960b5a8c4d702fceb>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

25

113 R.A. Asherson; G. Espinosa; R. Cervera; J. Font; J.C. Reverter. Catastrophic antiphospholipidsyndrome: Proposed guidelines for diagnosis and treatment. Journal of Clinical Rheumatology. 8- 3, pp. 157 - 165. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036089429&partnerID=40&md5=6217fcd4eaf047f1f3acb0a7095585be>.Type of production: Scientific paper Format: Journal

114 F.-J. Muñoz Rodríguez; J.-C. Reverter; J. Font; D. Tàssies; G. Espinosa; R. Cervera; F. Carmona; J. Balasch;M. Ingelmo; A. Ordinas. Clinical significance of acquired activated protein C resistance in patients with systemiclupus erythematosus. Lupus. 11 - 11, pp. 730 - 735. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-18744408753&partnerID=40&md5=561c052c96fcc5f5bd4405167e04001d>.Type of production: Scientific paper Format: Journal

115 A.M. Galán; J.C. Reverter; M. Pino; M. Viñas; J. Bozzo; M.R. Hernández; J. Aznar Salatti; A. Ordinas; G. Escolar.Concentrates containing factor IX could improve haemostasis under conditions of thrombocytopenia: Studies in anin vitro model. Vox Sanguinis. 82 - 3, pp. 113 - 118. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0036551501&partnerID=40&md5=ad8e1443196bcc209464ef24b20b3778>.Type of production: Scientific paper Format: Journal

116 J. Font; G. Espinosa; D. Tàssies; M. Pino; M.A. Khamashta; T. Gallart; R. Cervera; G. Escolar; G.R.V.Hughes; M. Ingelmo; A. Ordinas; J.-C. Reverter. Effects of ?2-glycoprotein I and monoclonal anticardiolipinantibodies in platelet interaction with subendothelium under flow conditions. Arthritis and Rheumatism.46 - 12, pp. 3283 - 3289. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0036882165&partnerID=40&md5=2271ebc6e73350213805cff4d12539da>.Type of production: Scientific paper Format: Journal

117 J.C. Reverter. Fondaparinux sodium. Drugs of Today. 38 - 3, pp. 185 - 194.2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036525118&doi=10.1358%2fdot.2002.38.3.820126&partnerID=40&md5=2c5548b1af0dce9452981288238065cf>.Type of production: Scientific paper Format: Journal

118 J.C. Reverter. Fondaparinux sodium: Anticoagulant factor Xa inhibitor treatmentand prevention of deep vein thrombosis. Drugs of the Future. 27 - 2, pp. 122 -131. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036257889&doi=10.1358%2fdof.2002.027.02.656132&partnerID=40&md5=bc619034841d08f668deda8beb556822>.Type of production: Scientific paper Format: Journal

119 D. Tassies; C. Freire; J. Pijoan; S. Maragall; J. Monteagudo; A. Ordinas; J.C. Reverter. Pharmacogeneticsof acenocoumarol: Cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability ofanticoagulation. Haematologica. 87 - 11, pp. 1185 - 1191. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036854237&partnerID=40&md5=40ce304bde3675251ffa7f9d7af2dff1>.Type of production: Scientific paper Format: Journal

120 A.M. Galán; E. Casals; J. Estelirich; M.R. Hernández; J. Bozzo; J.C. Reverter; R. Mazzara; A. Ordinas; G.Escolar. Possible hemostatic effect of synthetic liposomes in experimental studies under flow conditions.Haematologica. 87 - 6, pp. 615 - 623. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036284787&partnerID=40&md5=c421901156588f41f39d1f1b01c2061b>.Type of production: Scientific paper Format: Journal

121 A. Perelló; J.C. García Pagán; R. Gilabert; Y. Suárez; E. Moitinho; F. Cervantes; J.C. Reverter; A. Escorsell; J.Bosch; J. Rodés. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolledby medical therapy. Hepatology. 35 - 1, pp. 132 - 139. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-18244366658&partnerID=40&md5=7f3417e3f7a6758c3bde94031c947721>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

26

122 T. Gallart; C. Benito; J.-C. Reverter; F. Bosch; M. Blay; D. Tàssies; E. Vigorito; R. Cervera;J. Font; R. Gomis; E. Campo; J. Vives. True anti-anionic phospholipid immunoglobulin mantibodies can exert lupus anticoagulant activity. British Journal of Haematology. 116 - 4,pp. 875 - 886. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036120929&doi=10.1046%2fj.0007-1048.2002.03335.x&partnerID=40&md5=588d3742b4d0f9009a7fba30dad9946a>.Type of production: Scientific paper Format: Journal

123 G. Espinosa; R. Cervera; J.-C. Reverter; D. Tàssies; J. Font; M. Ingelmo. Vascularinvolvement in Behçet's disease. Israel Medical Association Journal. 4 - 8, pp. 614 -616. 2002. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036341826&partnerID=40&md5=2cfcf22b7818e58652437637ce65b8e2>.Type of production: Scientific paper Format: Journal

124 G. Espinosa; J. Font; D. Tàssies; A. Vidaller; R. Deulofeu; A. López Soto; R. Cervera; A. Ordinas;M. Ingelmo; J.-C. Reverter. Vascular involvement in Behçet's disease: Relation with thrombophilicfactors, coagulation activation, and thrombomodulin. American Journal of Medicine. 112 -1, pp. 37 - 43. 2002. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-17944388772&partnerID=40&md5=c050c1159a8299704da9c89f2cec4647>.Type of production: Scientific paper Format: Journal

125 J. Sastre Garriga; J.C. Reverter; J. Font; M. Tintoré; G. Espinosa; X. Montalban. Anticardiolipin antibodiesare not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Annals ofNeurology. 49 - 3, pp. 408 - 411. 2001. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0035092781&partnerID=40&md5=0d9911521d920b2cecf53363c3469cfb>.Type of production: Scientific paper Format: Journal

126 G. Espinosa; D. Tagravessies; J. Font; F.J. Muntildeoz Rodriacuteguez; R. Cervera; A. Ordinas; J.C. Reverter;M. Ingelmo. Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. Seminars in Arthritis andRheumatism. 31 - 1, pp. 12 - 20. 2001. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0034885738&partnerID=40&md5=1c4f89f73b49419ee521fcb65289ec75>.Type of production: Scientific paper Format: Journal

127 G. Espinosa; J. Font; J.C. García Pagan; D. Tàssies; J.C. Reverter; C. Gaig; F. Cervantes; R. Cervera; J.Bosch; M. Ingelmo. Budd-Chiari syndrome secondary to antiphospholipid syndrome: Clinical and immunologiccharacteristics of 43 patients. Medicine. 80 - 6, pp. 345 - 354. 2001. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0035170013&partnerID=40&md5=623e1ccd575e60a46fd9830c2010af74>.Type of production: Scientific paper Format: Journal

128 J.C. Reverter. Antiplatelet therapy [Antiagregantes plaquetarios]. Medicina Clinica. 115 - 6,pp. 214 - 215. 2000. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034622192&partnerID=40&md5=971444a4871eea98e5aeed01d099fa79>.Type of production: Scientific paper Format: Journal

129 A. Salas; M. Sans; A. Soriano; J.M. Piqué; J. Panés; J.C. Reverter; D.C. Anderson. Heparinattenuates TNF-? induced inflammatory response through a CD11b dependent mechanism. Gut.47 - 1, pp. 88 - 15. 2000. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0033945430&partnerID=40&md5=e05bee6c99a1921da0ee561563ba024f>.Type of production: Scientific paper Format: Journal

130 A.-M. Galán; J. Bozzo; M.-R. Hernández; M. Pino; J.-C. Reverter; R. Mazzara; G. Escolar; A. Ordinas. Infusibleplatelet membranes improve hemostasis in thrombocytopenic blood: Experimental studies under flow conditions.Transfusion. 40 - 9, pp. 1074 - 1080. 2000. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033823078&doi=10.1046%2fj.1537-2995.2000.40091074.x&partnerID=40&md5=bf6daccba2a2bedf5fee7cc048e7e18e>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

27

131 N. Vila; J.C. Reverter; J. Yagüe; A. Chamorro. Interaction between interleukin-6 and the naturalanticoagulant system in acute stroke. Journal of Interferon and Cytokine Research. 20 - 3,pp. 325 - 329. 2000. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034073852&doi=10.1089%2f107999000312478&partnerID=40&md5=463b94d9649acd6b4c55ac7a57077232>.Type of production: Scientific paper Format: Journal

132 D. Millar; G. Kemball Cook; J. McVey; E. Tuddenham; A. Mumford; G. Attock; J. Reverter; N. Lanir; L.Parapia; J. Reynaud; E. Meili; A. Von Felton; U. Martinowitz; D. Prangnell; M. Krawczak; D. Cooper.Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Human Genetics.107 - 4, pp. 327 - 342. 2000. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0033757946&partnerID=40&md5=3f66d3c9f41821e2d8bd82fdff0ba3ee>.Type of production: Scientific paper Format: Journal

133 D.S. Millar; L. Elliston; P. Deex; M. Krawczak; A.I. Wacey; J. Reynaud; H.K. Nieuwenhuis; P. BoltonMaggs; P.M. Mannucci; J.C. Reverter; P. Cachia; K.J. Pasi; D.M. Layton; D.N. Cooper. Molecularanalysis of the genotype-phenotype relationship in factor X deficiency. Human Genetics. 106 -2, pp. 249 - 257. 2000. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-18844480017&partnerID=40&md5=a1a79e963da795cc5817be745d80d56b>.Type of production: Scientific paper Format: Journal

134 F.-J. Muñoz Rodríguez; J.-C. Reverter; J. Font; D. Tàssies; R. Cervera; G. Espinosa; F. Carmona; J.Balasch; A. Ordinas; M. Ingelmo. Prevalence and clinical significance of antiprothrombin antibodies inpatients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica.85 - 6, pp. 632 - 637. 2000. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-18844471340&partnerID=40&md5=3d59f909df52da02297199e2e90d96db>.Type of production: Scientific paper Format: Journal

135 D. Tássies; G. Espinosa; F.J. Muñoz-RodríGuez; C. Freire; R. Cervera; J. Monteagudo; S. Maragal; G.Escolar; M. Ingelmo; A. Ordinas; J. Font; J.C. Reverter. The 4G/5G polymorphism of the type 1 plasminogenactivator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis and Rheumatism.43 - 10, pp. 2349 - 2358. 2000. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033785047&doi=10.1002%2f1529-0131%28200010%2943%3a10%26lt%3b2349%3a%3aAID-ANR24%26gt%3b3.0.CO%3b2-J&partnerID=40&md5=66de063181ed0168400b2edd2959e835>.Type of production: Scientific paper Format: Journal

136 A.M. Galan; J.C. Reverter; J. Bozzo; M.R. Hernandez; G. Escolar; J. Aznar Salatti. Assessment of potentialthrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis. ThrombosisResearch. 96 - 5, pp. 383 - 389. 1999. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0032801401&partnerID=40&md5=d9c1d9049f04a87e930f09a01ac24b61>.Type of production: Scientific paper Format: Journal

137 F.J. Muoz Rodríguez; J. Font; R. Cervera; J.C. Reverter; D. Tàssies; G. Espinosa; A. López Soto; F. Carmona; J.Balasch; A. Ordinas; M. Ingelmo. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.Seminars in Arthritis and Rheumatism. 29 - 3, pp. 182 - 190. 1999. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0033386110&partnerID=40&md5=516f9ca9d6032367ef0106548fbe4379>.Type of production: Scientific paper Format: Journal

138 A. Cases; M. Diaz Ricart; J.C. Reverter; D. Tassies; G. Escolar. Erythropoietin: Plateletsand endothelium [Eritropoyetina: Plaquetas y endotelio]. Nefrologia. 19 - SUPPL. 3, pp.12 - 16. 1999. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0032878283&partnerID=40&md5=9d5e52c00d3829fcea7a635e60617821>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

28

139 A. Chamorro; G. Escolar; M. Revilla; V. Obach; N. Vila; J.C. Reverter; A. Ordinas. Ex vivoresponse to aspirin differs in stroke patients with single or recurrent events: A pilot study.Journal of the Neurological Sciences. 171 - 2, pp. 110 - 114. 1999. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032700388&doi=10.1016%2fS0022-510X%2899%2900260-9&partnerID=40&md5=5c84255b1e98f848d022b54d9a14cfff>.Type of production: Scientific paper Format: Journal

140 D. Tàssies; M. Magallón; M. Quintana; M. Fernández Urgellés; C. Rodriguez Pinto; J. Tusell;C. Altisent; J.-C. Reverter; R. Mazzara; A. Ordinas; J. Monteagudo. Hepatitis G virus infectionmarkers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs. Haematologica. 84- 10, pp. 930 - 936. 1999. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0345466603&partnerID=40&md5=8b7f44e69f70157513fd6a273212b82e>.Type of production: Scientific paper Format: Journal

141 J. Balasch; J.C. Reverter; M. Creus; D. Tassies; F. Fábregues; F. Carmona; J. Font; J.A. Vanrell.Human reproductive failure is not a clinical feature associated with ?2 glycoprotein-I antibodiesin anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactorsyndrome). Human Reproduction. 14 - 8, pp. 1956 - 1959. 1999. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032804578&doi=10.1093%2fhumrep%2f14.8.1956&partnerID=40&md5=c5b419f1ea4ee272c54e2b45445e50c4>.Type of production: Scientific paper Format: Journal

142 F.J. Muñoz Rodríguez; D. Tàssies; J. Font; J.C. Reverter; R. Cervera; J.M. Sánchez Tapias; R. Mazzara; A.Ordinas; M. Ingelmo. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. Journalof Hepatology. 30 - 5, pp. 770 - 773. 1999. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0038140467&partnerID=40&md5=14a63635b9f3d302740c15b5c97f45d6>.Type of production: Scientific paper Format: Journal

143 J. Balasch; M. Creus; F. Fábregues; S. Cívico; J.C. Reverter; F. Carmona; D. Tàssies; J.A. Vanrell.Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization andembryo transfer cycle. Human Reproduction. 13 - 5, pp. 1180 - 1183. 1998. Available on-line at:<https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031809891&doi=10.1093%2fhumrep%2f13.5.1180&partnerID=40&md5=b911ecf660c8a490b5dded174b9a0526>.Type of production: Scientific paper Format: Journal

144 D. Tàssies; J.C. Reverter; A. Cases; J. Calls; G. Escolar; A. Ordinas. Effect of recombinant humanerythropoietin treatment on circulating reticulated platelets in uremic patients: Association with earlyimprovement in platelet function. American Journal of Hematology. 59 - 2, pp. 105 - 109. 1998. Availableon-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031665597&doi=10.1002%2f%28SICI%291096-8652%28199810%2959%3a2%26lt%3b105%3a%3aAID-AJH1%26gt%3b3.0.CO%3b2-1&partnerID=40&md5=f5658d7e9f7aa98c1e2f45e6ef299351>.Type of production: Scientific paper Format: Journal

145 J.-C. Reverter; D. Tàssies; J. Font; M.A. Khamashta; K. Ichikawa; R. Cervera; G. Escolar; G.R.V.Hughes; M. Ingelmo; A. Ordinas. Effects of human monoclonal anticardiolipin antibodies onplatelet function and on tissue factor expression on monocytes. Arthritis and Rheumatism. 41 - 8,pp. 1420 - 1427. 1998. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031876263&doi=10.1002%2f1529-0131%28199808%2941%3a8%26lt%3b1420%3a%3aAID-ART11%26gt%3b3.0.CO%3b2-U&partnerID=40&md5=3018a1bfd2f2b4dd5a9d0b925a662d7d>.Type of production: Scientific paper Format: Journal

146 J. Font; D. Tàssies; M. García Carrasco; M. Ramos Casals; R. Cervera; J.C. Reverter; J.M.Sánchez Tapias; R. Mazzara; M. Ingelmo. Hepatitis G virus infection in primary Sjogren'ssyndrome: Analysis in a series of 100 patients. Annals of the Rheumatic Diseases. 57 - 1,

ce46abfe1b997dc092066835783957ac

29

pp. 42 - 44. 1998. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0031948364&partnerID=40&md5=74e2d99ecca6b31da5ce6425c6ba4218>.Type of production: Scientific paper Format: Journal

147 A.M. Galán; M.R. Hernández; J. Bozzo; J.C. Reverter; J. Estelrich; T. Roy; R. Mazzara; A. Ordinas; G. Escolar.Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels: Studies under flowconditions. Transfusion. 38 - 11-12, pp. 1004 - 1010. 1998. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031767377&partnerID=40&md5=c233256c2c20d1b4781923c917eb6eb1>.Type of production: Scientific paper Format: Journal

148 M. Navarro; R. Cervera; J. Font; J.C. Reverter; J. Monteagudo; G. Escolar; A. López-Soto; A. Ordinas; M.Ingelmo. Anti-endothelial cell antibodies in systemic autoimmune diseases: Prevalence and clinical significance.Lupus. 6 - 6, pp. 521 - 526. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030769770&partnerID=40&md5=e08228768146e61af23a0f0903339c47>.Type of production: Scientific paper Format: Journal

149 J. Font; A. López-Soto; R. Cervera; F.J. Casals; J.C. Reverter; F.J. Muñoz; C. Miret; A. Bové;A. Ordinas; M. Ingelmo. Antibodies to thromboplastin in systemic lupus erythematosus: Isotypedistribution and clinical significance in a series of 92 patients. Thrombosis Research. 86 - 1,pp. 37 - 48. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0343554055&doi=10.1016%2fS0049-3848%2897%2900043-1&partnerID=40&md5=27a95977397e8557bfda1d2adbad4973>.Type of production: Scientific paper Format: Journal

150 R. Cervera; M. García Carrasco; J. Font; M. Ramos; J.C. Reverter; F.J. Muñoz; C. Miret; G.Espinosa; M. Ingelmo. Antiphospholipid antibodies in primary Sjogren's syndrome: Prevalenceand clinical significance in a series of 80 patients. Clinical and Experimental Rheumatology. 15- 4, pp. 361 - 365. 1997. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-1842368462&partnerID=40&md5=aff99081a6d874c13a0fe7472ffd9e55>.Type of production: Scientific paper Format: Journal

151 C. Miret; R. Cervera; J.C. Reverter; M. García Carrasco; M. Ramos; M. Mollà; J. Font; M. Ingelmo.Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event:Transient 'seronegative' antiphospholipid syndrome?. Clinical and Experimental Rheumatology.15 - 5, pp. 541 - 544. 1997. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0030885477&partnerID=40&md5=218f6316dd668d2c64938bdad9352e40>.Type of production: Scientific paper Format: Journal

152 A. Serra; J. Esteve; J.C. Reverter; M. Lozano; G. Escolar; A. Ordinas. Differential effectof a low-molecular-weight heparin (dalteparin) and unfractionated heparin on plateletinteraction with the subendothelium under flow conditions. Thrombosis Research. 87 - 4,pp. 405 - 410. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030754726&doi=10.1016%2fS0049-3848%2897%2900144-8&partnerID=40&md5=fab2fa8b29035477c5751d50015617ea>.Type of production: Scientific paper Format: Journal

153 J. Balasch; J.C. Reverter; F. Fábregues; D. Tàssies; M. Rafel; M. Creus; J.A. Vanrell. First-trimesterrepeated abortion is not associated with activated protein C resistance. Human Reproduction. 12 -5, pp. 1094 - 1097. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030940343&partnerID=40&md5=a3b3dc292f66b000a295c8ad898affe3>.Type of production: Scientific paper Format: Journal

154 R. Castillo; G. Escolar; J. Monteagudo; J. Aznar Salatti; J.C. Reverter; A. Ordinas. Hemostasis in patients withsevere von willebrand disease improves after normal platelet transfusion and normalizes with further correction ofthe plasma defect. Transfusion. 37 - 8, pp. 785 - 790. 1997. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0030863249&partnerID=40&md5=404bf63f7f6a129da2c3eb700afcb58e>.

ce46abfe1b997dc092066835783957ac

30

Type of production: Scientific paper Format: Journal

155 M. Alemany; M.R. Hernandez; J. Bozzo; A.M. Galan; J.C. Reverter; R. Mazzara; A. Ordinas; G.Escolar. In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations:Studies with frozen-thawed, sonicated or lyophilized platelets. Vox Sanguinis. 73 - 1, pp.36 - 42. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030797169&partnerID=40&md5=f91ab612d00940be2fb0140b86bf8c26>.Type of production: Scientific paper Format: Journal

156 A. Cases; J.C. Reverter; G. Escolar; C. Sanz; J. Sorribes; A. Ordinas. In vivo evaluationof platelet activation by different cellulosic membranes. Artificial Organs. 21 - 4, pp. 330- 334. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030964414&partnerID=40&md5=18a76e2d654db42a3709bc47e3f1199f>.Type of production: Scientific paper Format: Journal

157 A. López Soto; R. Cervera; J. Font; A. Bové; J.C. Reverter; F.J. Muñoz; C. Miret; G. Espinosa;A. Ordinas; M. Ingelmo. Isotype distribution and clinical significance of antibodies to cardiolipin,phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus:Prospective analysis of a series of 92 patients. Clinical and Experimental Rheumatology. 15 -2, pp. 143 - 149. 1997. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-15144349600&partnerID=40&md5=2442fa070b49dac85cbcbf3f16e4bfed>.Type of production: Scientific paper Format: Journal

158 J.L. Reverter; J.C. Reverter; D. Tàssies; F. Rius; J. Monteagudo; J. Rubiés Prat; G. Escolar; A. Ordinas;A. Sanmartí. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabeticmicroangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus.American Journal of Hematology. 56 - 2, pp. 93 - 99. 1997. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0030761061&partnerID=40&md5=2b0c4e880269118660a5918f8130005a>.Type of production: Scientific paper Format: Journal

159 M. Teixidó; J. Font; J.C. Reverter; R. Cervera; D. Tàssies; M. Ingelmo; G. Escolar; A. Ordinas. antiphospholipidsyndrome Anti-?2-glycoprotein I antibodies: A useful marker for the antiphospholipid syndrome. British Journal ofRheumatology. 36 - 1, pp. 113 - 116. 1997. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030641981&partnerID=40&md5=e4ad58da52f9b9c87af8432a39db03f4>.Type of production: Scientific paper Format: Journal

160 M. Navarro; R. Cervera; M. Teixidó; J.C. Reverter; J. Font; A. López Soto; J. Monteagudo; G. Escolar; M. Ingelmo.Antibodies to endothelial cells and to ?2-glycoprotein I in the antiphospholipid syndrome: Prevalence and isotypedistribution. Revmatologiia. 35 - 6, pp. 523 - 528. 1996. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0029976528&partnerID=40&md5=d713a84e520f446d05a3e2e6fd968666>.Type of production: Scientific paper Format: Journal

161 J. Balasch; M. Creus; F. Fábregues; J.C. Reverter; F. Carmona; D. Tàssies; J. Font; J.A. Vanrell.Antiphospholipid antibodies and human reproductive failure. Human Reproduction. 11 - 10,pp. 2310 - 2315. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029804117&partnerID=40&md5=a7d319e009d2624bca709ff7d6600b60>.Type of production: Scientific paper Format: Journal

162 E. Montserrat; N. Villamor; J.-C. Reverter; R.-M. Brugués; D. Tàssies; F. Bosch; J.-L. Aguilar; J.-L.Vives-Corrons; M. Rozman; C. Rozma. Bone marrow assessment in B-cell chronic lymphocyticleukaemia: Aspirate or biopsy? A comparative study in 258 patients. British Journal of Haematology.93 - 1, pp. 111 - 116. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-9244241476&doi=10.1046%2fj.1365-2141.1996.449988.x&partnerID=40&md5=2f9b73a47b0a0cd15a21f2be6ea79ff6>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

31

163 D. Tàssies; J.C. Reverter; G. Escolar; M. Viñas; M. Lozano; M. Pino; M. Heras; A. Ordinas. Effects ofthrombolytic agents on platelet function and glycoprotein expression in a perfusion system. Fibrinolysis.10 - SUPPL. 3, pp. 54 - 54. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846672996&partnerID=40&md5=42a735194b69029fe9d9a8b048c2710d>.Type of production: Scientific paper Format: Journal

164 G. Gutiérrez; J.M. Jou; J.C. Reverter; F. Martínez Brotons; A. Domingo; J.A. Iriarte; A. Remacha; J.Rey; J.L.V. Corrons. External quality assurance programme for general haematology. Evaluation ofthe 1994 results [Comité de Estandarización en Hematología Programa de Evaluación Externa dela Calidad en Hematologí. general Valoración de los resultados correspondientes a 1994]. Sangre.41 - 2, pp. 115 - 124. 1996. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0030113910&partnerID=40&md5=ef8509ffb09ecbc2a169d3af3e66b437>.Type of production: Scientific paper Format: Journal

165 J.-C. Reverter; D. Tàssies; J. Font; J. Monteagudo; G. Escolar; M. Ingelmo; A. Ordinas. Hypercoagulablestate in patients with antiphospholipid syndrome is related to high induced tissue factor expressionon monocytes and to low free protein S. Arteriosclerosis, Thrombosis, and Vascular Biology. 16 -11, pp. 1319 - 1326. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029911062&partnerID=40&md5=c71f88dc2976f863ef57c07401f53fc2>.Type of production: Scientific paper Format: Journal

166 R. Sala; J.M. Miró; E. Feliu; J.L. Bianchi; J.M. Gatell; J.C. Reverter; E. Soriano; J. García San Miguel. In vitro effectof the heroin on peripheral blood neutrophil polymorphonuclear leukocytes function [Estudio in vitro del efectode la heroína sobre la función de los leucocitos polimorfonucleares neutrófilos de la sangre periférica]. MedicinaClinica. 107 - 19, pp. 726 - 729. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030607532&partnerID=40&md5=1b4155c20c649ff669bbcb510f59f4fb>.Type of production: Scientific paper Format: Journal

167 J. Balasch; J.C. Reverter; F. Fabregues; D. Tassies; A. Ordinas; J.A. Vanrell. Increased induced monocytetissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome. Fertility andSterility. 66 - 4, pp. 608 - 613. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029831124&partnerID=40&md5=c704162d93c5656164642de875fb12f2>.Type of production: Scientific paper Format: Journal

168 J.C. Reverter; S. Béguin; H. Kessels; R. Kumar; H.C. Hemker; B.S. Coller. Inhibition of platelet-mediated,tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: Potential implicationsfor the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. Journal of ClinicalInvestigation. 98 - 3, pp. 863 - 874. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029914728&partnerID=40&md5=05ba4fe5f301ccb66fd95ec90901f604>.Type of production: Scientific paper Format: Journal

169 J.C. Reverter; J. Monteagudo; D. Tassies. Rbrinolysis, thrombin generation and endothelialcell damage in patients with antiphospholipid antibodies. Fibrinolysis. 10 - SUPPL. 3, pp.50 - 50. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846672738&partnerID=40&md5=6f5e76070253a48f88ea89bedeb90e4f>.Type of production: Scientific paper Format: Journal

170 M. Sans; J. Llach; J.M. Bordas; V. Andreu; J.C. Reverter; J. Bosch; F. Mondelo; J.M. Salmerón; A. Mas; J. Terés;J. Rodés. Thrombin and ethanolamine injection therapy in arresting uncontrolled bleeding from duodenal varices.Endoscopy. 28 - 4, pp. 403 - 403. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-8944236538&partnerID=40&md5=f813e3cea5cdcad9a273641caf05be36>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

32

171 R.M. Martí; T. Estrach; J.C. Reverter; E. Campo; R. Brugués; M. Bruguera; J.M. Mascaró. Utility of bonemarrow and liver biopsies for staging cutaneous T-cell lymphoma. International Journal of Dermatology.35 - 6, pp. 450 - 454. 1996. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030004291&partnerID=40&md5=7ff3dcbf2db48729084dfc760f81b1ff>.Type of production: Scientific paper Format: Journal

172 J.L. Vives Corrons; G. Gutiérrez; J.M. Jou; J.C. Reverter; F. Martínez Brotons; A. Domingo; J.A.Iriarte. Characteristics and performance of the external quality assessment scheme (EQAS)for haematology in Spain. Ten years of experience.Annali dell'Istituto superiore di sanità. 31 -1, pp. 95 - 101. 1995. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0029441240&partnerID=40&md5=bd231796e926ef27ae1673c90e7bbd1f>.Type of production: Scientific paper Format: Journal

173 J.-C. Reverter; D. Tassies; G. Escolar; J. Font; A.L. Soto; M. Ingelmo; A. Ordinas. Effect of plasma from patientswith primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system. Thrombosis andHaemostasis. 73 - 1, pp. 132 - 137. 1995. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028836875&partnerID=40&md5=71d15199195ea1119d9a32cae721d751>.Type of production: Scientific paper Format: Journal

174 J.C. Reverter; D. Tassies; S. Maragall; J. Monteagudo; G. Escolar; A. Ordinas. Hemorrhagic accidentsduring prolonged ambulatory treatment with acenocumarol [ACCIDENTES HEMORRAGICOS DURANTEEL TRATAMIENTO AMBULATORIO PROLONGADO CON ACENOCUMAROL]. Medicina Clinica.105 - 4, pp. 127 - 130. 1995. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029056514&partnerID=40&md5=729a8ec4df523e82db5b1ebc809833ac>.Type of production: Scientific paper Format: Journal

175 D. Tàssies; E. Montserrat; J.C. Reverter; N. Villamor; M. Rovira; C. Rozman. Myelomonocytic antigens in B-cellchronic lymphocytic leukemia. Leukemia Research. 19 - 11, pp. 841 - 848. 1995. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029610836&doi=10.1016%2f0145-2126%2895%2900064-X&partnerID=40&md5=057208a66dd6fac399aeb247ef2e3104>.Type of production: Scientific paper Format: Journal

176 D. Tassies; J.?C. Reverter; A. Cases; G. Escolar; N. Villamor; J. López?Pedret; R.Castillo; A. Ordinas. Reticulated platelets in uremic patients: Effect of hemodialysis andcontinuous ambulatory peritoneal dialysis. American Journal of Hematology. 50 - 3, pp.161 - 166. 1995. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028875934&doi=10.1002%2fajh.2830500303&partnerID=40&md5=35ee62882a8773309cf466bc555d83e7>.Type of production: Scientific paper Format: Journal

177 R. Cervera; M. Navarro; A. Lopez Soto; M.-C. Cid; J. Font; J. Esparza; J.C. Reverter; J. Monteagudo;M. Ingelmo; A. Urbano Marquez. Antibodies to endothelial cells in Behcet's disease: Cell-bindingheterogeneity and association with clinical activity. Annals of the Rheumatic Diseases. 53 - 4,pp. 265 - 267. 1994. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0028226462&partnerID=40&md5=f5ad5f2692d2f7280705e633892e2e4a>.Type of production: Scientific paper Format: Journal

178 J.C. Reverter; E. Montserrat. Detection of abdominal involvement in Hodgkin's disease: Isthere still a role for staging laparotomy?. Hematology Reviews and Communications. 8 - 4,pp. 273 - 286. 1994. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028067829&partnerID=40&md5=45d0ba7704a8a14ff5fb47ae97851803>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

33

179 A. Cases; J.C. Reverter; G. Escolar; J. Sorribes; J. Lopez Pedret; L. Revert; A. Ordinas. Effect of recombinanthuman erythropoietin treatment on coagulation and fibrinolysis in uremic patients [EFECTO DEL TRATAMIENTOCON ERITROPOYETINA RECOMBINANTE HUMANA SOBRE LA COAGULACION Y LA FIBRINOLISIS].Nefrologia. 14 - 1, pp. 87 - 91. 1994. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028214394&partnerID=40&md5=0fdb3c8c9097773dbbe38a0cf7f70ac3>.Type of production: Scientific paper Format: Journal

180 J. Blade; A. Lopez Guillermo; F. Bosch; F. Cervantes; J.-C. Reverter; E. Montserrat; C. Rozman. Impact ofresponse to treatment on survival in multiple myeloma: Results in a series of 243 patients. British Journal ofHaematology. 88 - 1, pp. 117 - 121. 1994. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0027936099&partnerID=40&md5=3f1867bd33388db150563677434d53b2>.Type of production: Scientific paper Format: Journal

181 A. Lopez-Guillermo; E. Montserrat; F. Bosch; L. Escoda; M.J. Terol; P. Marin; J.C. Reverter; J. Blade; F.Cervantes; J. Sierra; B. Nomdedeu; A. Urbano-Ispizua; M. Rouira; E. Carreras; E. Campo; C. Rozman. Low-gradelymphoma: Clinical and prognostic studies in a series of 143 patients from a single institution. Leukemia andLymphoma. 15 - 1-2, pp. 159 - 165. 1994. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027978359&doi=10.3109%2f10428199409051692&partnerID=40&md5=6c17d493d6977ec0874c6d3bd690da6b>.Type of production: Scientific paper Format: Journal

182 J.C. Reverter; G. Escolar; C. Sanz; A. Cases; N. Villamor; H.K. Nieuwenhuis; J. López; A. Ordinas.Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flowcytometric and ultrastructural techniques. The Journal of Laboratory and Clinical Medicine. 124- 1, pp. 79 - 85. 1994. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028472043&partnerID=40&md5=cc2654f6d3ffaa54c51fe27ed71e0c70>.Type of production: Scientific paper Format: Journal

183 J. Blade; J.C. Reverter. Postsplenectomy sepsis in Hodgkin's disease: Assessment ofthe risk and clinical approach. Hematology Reviews and Communications. 8 - 4, pp. 287- 294. 1994. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028076931&partnerID=40&md5=2194f0d6d4aee50bb337271699a01b5b>.Type of production: Scientific paper Format: Journal

184 J. Vivancos; A. Lopez Soto; J. Font; J. Balasch; R. Cervera; J.C. Reverter; F. Carmona; M.Ingelmo. Primary antiphospholipid syndrome: Clinical and biological study of 36 cases [SINDROMEANTIFOSFOLIPIDO PRIMARIO: ESTUDIO CLINICO Y BIOLOGICO DE 36 CASOS]. Medicina Clinica.102 - 15, pp. 561 - 565. 1994. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0028779136&partnerID=40&md5=e14427b9cbdf4a9a89495216d773c134>.Type of production: Scientific paper Format: Journal

185 J. Rivera; M.J.S. Roig; J. Monteagudo; A. Pereira; J.M. Moraleda; J.C. Reverter; V. Vicente.Absence of effect of DDAVP infusion on platelet glycoprotein ib/IX and IIb/IIIa complexes,and their interaction with newly released von willebrand factor. Platelets. 4 - 4, pp. 219- 224. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027283502&doi=10.3109%2f09537109309013221&partnerID=40&md5=fcb1566486a67a8011e1903c7a1a3bda>.Type of production: Scientific paper Format: Journal

186 C. Rozman; E. Feliu; M. Rozman; J.C. Reverter; C. Climent; L. Berga. Acquired aplastic anemia: astereological analysis of bone marrow fatty tissue and its clinical correlations [Aplasia medular adquirida:análisis estereológico del tejido adiposo de la medula ósea y sus correlaciones clínicas.]. Medicina Clinica.101 - 12, pp. 441 - 445. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027919010&partnerID=40&md5=fc1bb70ddd308dbc8d17e76ae633cba1>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

34

187 C. Rozman; J.C. Reverter; E. Feliu; M. Rozman; C. Climent; L. Berga. Adaptation of human bonemarrow adipose tissue to different grades of hemopoietic cellularity [Sobre la adaptación del tejidoadiposo de la medula ósea humana a diferentes grados de celularidad hemopoyética.]. Sangre. 38- 2, pp. 121 - 124. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027584657&partnerID=40&md5=3ac963fa94c4bba183a4adc251788511>.Type of production: Scientific paper Format: Journal

188 J. Sierra; E. Conde; A. Iriondo; S. Brunet; J. Marín; J.P. de Oteiza; D. Caballero; F. Martínez; A. León; J.García Conde; F. Hernández Navarro; A. Domingo; D. Carrera; J.C. Reverter; C. Richard; J. Zuazu; J. Baro;J. Rifón; C. Solano; J. Díaz Mediavilla; C. Rozman; E. Montserrat. Frozen vs. nonfrozen bone marrow forautologous transplantation in lymphomas: A report from the Spanish GEL/TAMO Cooperative Group. Annals ofHematology. 67 - 3, pp. 111 - 114. 1993. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0027209363&partnerID=40&md5=6b1032906f77be93857afbdb806b2f39>.Type of production: Scientific paper Format: Journal

189 A. Lopez-guillermo; E. Montserrat; J.C. Reverter; F. Cervantes; L. Escoda; D. Tassies; J. Blade;P. Marin; J. Sierra; J. Ordi; C. Rozman. Large-cell lymphoma: A study of prognostic factors andassessment of five recently proposed predictive systems. Leukemia and Lymphoma. 10 - 1-2,pp. 101 - 109. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027166060&doi=10.3109%2f10428199309147362&partnerID=40&md5=36e401ed731dfa27a75b70e2663cf110>.Type of production: Scientific paper Format: Journal

190 A. Cases; J.C. Reverter; G. Escolar; C. Sanz; J. Lopez Pedret; L. Revert; A. Ordinas. Plateletactivation on hemodialysis: Influence of dialysis membranes. Kidney International, Supplement.41, pp. S - 220. 1993. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0000791047&partnerID=40&md5=578a3729845ec73c23440f9dc407696d>.Type of production: Scientific paper Format: Journal

191 J. Monteagudo; J.C. Reverter; A. Pereira; J. Pijoan; J. Balust; G. Escolar; R. Mazzara; P.Taurá; J. Visa; A. Ordinas; R. Castillo. Prothrombin fragment 1+2 and thrombin-antithrombincomplex measurements indicate continuous and progressive intraoperative thrombingeneration in liver transplantation. Pathophysiology of Haemostasis and Thrombosis. 23 - 1,pp. 51 - 57. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-20244371478&doi=10.1159%2f000216852&partnerID=40&md5=ff7aedcbe27f115b3cc26edb748a76c5>.Type of production: Scientific paper Format: Journal

192 D.S. Millar; A. Lopez; D. White; G. Abraham; B. Laursen; S. Holding; J.C. Reverter; J. Reynaud; U.Martinowitz; J.P.L.A. Hayes; V.V. Kakkar; D.N. Cooper. Screening for mutations in the antithrombin IIIgene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis. HumanMutation. 2 - 4, pp. 324 - 326. 1993. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0027221054&partnerID=40&md5=208da87604c1b5e6eb1622d766b26167>.Type of production: Scientific paper Format: Journal

193 J.-C. Reverter; E. Feliu; C. Climent; M. Rozman; L. Berga; C. Rozman. Stereological study of human bonemarrow adipocytes. A comparison of four methods for estimating size distributions. Pathology Research andPractice. 189 - 10, pp. 1215 - 1220. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027722950&partnerID=40&md5=e7ed47d6735b62ddcf80a41e4d7ada81>.Type of production: Scientific paper Format: Journal

194 C. Rozman; J.C. Reverter; E. Feliu; M. Rozman; C. Climent; L. Berga. The adaptation of human bonemarrow adipose tissue to various degrees of hematopoietic cellularity [Sobre la adaptación del tejidoadiposo de la medula ósea humana a diferentes grados de celularidad hemopoyética.]. Sangre. 38- 3, pp. 217 - 220. 1993. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027613137&partnerID=40&md5=dacc32f444e395f2a98bad73aceff95e>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

35

195 G. Escolar; M. Diaz?Ricart; M. Garrido; J.C. Reverter; N. Villamor; C. Sanz; S. Maragall; R. Castillo;A. Ordinas; A.T. Nurden. A variant of Glanzmann's thrombasthenia which fails to express a GPIIb–IIIarelated epitope that is recognized by a specific monoclonal antibody (C17). British Journal of Haematology.81 - 4, pp. 545 - 551. 1992. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026686512&doi=10.1111%2fj.1365-2141.1992.tb02990.x&partnerID=40&md5=1a6203c1fb8f4860d6dc78ccd7ad6f4e>.Type of production: Scientific paper Format: Journal

196 J.C. Garcia Valdecasas; J. Angâs; J.C. Reverter; A.M. Lacy; L. Grande; J. Faster; X. Filella; E. Cugat; J.M.Piqué; J.J. Grau; F.J. Gonzalez; J. Visa; C. Pera. Colorectal carcinoma: Results of a follow-up protocol. DigestiveSurgery. 9 - 4, pp. 204 - 208. 1992. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0027049140&partnerID=40&md5=be7576eb95972765b6b654de81c070a8>.Type of production: Scientific paper Format: Journal

197 R. Castillo; G. Escolar; J. Monteagudo; J.C. Reverter; A. Ordinas. Hemostatic effect ofplatelet von willebrand factor. Pathophysiology of Haemostasis and Thrombosis. 22 - 5, pp.233 - 235. 1992. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026618798&doi=10.1159%2f000216328&partnerID=40&md5=16d80b7f882a179d562fe48967098903>.Type of production: Scientific paper Format: Journal

198 H.D. Bruhn; J. Conard; M. Mannucci; J. Monteagudo; H. Pelzer; J.C. Reverter; M. Samama; A. Tripodi; C.Wagner. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination. Thrombosis andHaemostasis. 68 - 4, pp. 413 - 417. 1992. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026758761&partnerID=40&md5=352b2915fbab7d89c789515cd87cac7b>.Type of production: Scientific paper Format: Journal

199 G. Escolar; J. Font; J.C. Reverter; A. López Soto; M. Garrido; R. Cervera; M. Ingelmo; R. Castillo; A.Ordinas. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotesplatelet aggregation: Studies in a perfusion system. Arteriosclerosis, Thrombosis, and Vascular Biology.12 - 2, pp. 196 - 200. 1992. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026582938&partnerID=40&md5=10535cd2a61eeced81408aa3e9999df0>.Type of production: Scientific paper Format: Journal

200 N. Villamor; J.-C. Reverter; E. Montserrat; A. Urbano Ispízua; J.-L. Vives Corrons; C. Rozman. Recombinantalpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.Leukemia. 6 - 6, pp. 547 - 552. 1992. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026741452&partnerID=40&md5=aff8b1e86d869ecf41cb3f455322e76c>.Type of production: Scientific paper Format: Journal

201 A. Cases; G. Escolar; J.C. Reverter; A. Ordinas; J. Lopez Pedret; L. Revert; R. Castillo. Recombinanthuman erythropoietin treatment improves platelet function in uremic patients. Kidney International.42 - 3, pp. 668 - 672. 1992. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026787986&partnerID=40&md5=4ceec8d05922d94d1055d135abaf05a7>.Type of production: Scientific paper Format: Journal

202 C. Rozman; J.C. Reverter; E. Feliu; M. Rozman; C. Climent; L. Berga. Stereological study of the fatcells in bone marrows with a heterogeneous distribution of adipose tissue [Estudio estereológicode las células grasas en medulas óseas con distribución heterogénea del tejido adiposo.]. Sangre.37 - 5, pp. 369 - 373. 1992. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026937101&partnerID=40&md5=cb322303ead3c58456e4d9ee0e58bca2>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

36

203 A. Urbano Ispizua; E. Matutes; N. Villamor; J. Sierra; A. Pujades; J.-C. Reverter; E. Feliu; F.Cervantes; J.-L. Vives Corrons; E. Montserrat; C. Rozman. The value of detecting surfaceand cytoplasmic antigens in acute myeloid leukaemia. British Journal of Haematology. 81 - 2,pp. 178 - 183. 1992. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026632452&partnerID=40&md5=0104c6489910bbc1b514f4e9bf5914fe>.Type of production: Scientific paper Format: Journal

204 E. Montserrat; N. Viñolas; J.-C. Reverter; M. Rovira; C. Rozman. "smouldering"chronic lymphocytic leukemia. Leukemia and Lymphoma. 5 - S1, pp. 183 - 187.1991. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026326775&doi=10.3109%2f10428199109103403&partnerID=40&md5=72a7d784f2ce7b6c18c81e0fd8267520>.Type of production: Scientific paper Format: Journal

205 J.L. Vives corrons; J.M. Jou; C. Pastor; J.C. Reverter; C. Jou. Characteristics of the external qualityassessment (EQA) scheme for haematology in Spain. International Journal for Quality in HealthCare. 3 - 2, pp. 75 - 83. 1991. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-77957217343&partnerID=40&md5=636fca5e62aa749329afa2dafdb6cb23>.Type of production: Scientific paper Format: Journal

206 J.L. Vives Corrons; J.M. Jou; C. Pastor; J.C. Reverter; C. Jou. Characteristics of the externalquality assessment (EQA) scheme for haematology in Spain.Quality assurance in health care :the official journal of the International Society for Quality Assurance in Health Care / ISQA. 3- 2, pp. 75 - 83. 1991. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026305766&partnerID=40&md5=2745cd258ae9fb4db900ce3441932a79>.Type of production: Scientific paper Format: Journal

207 G.A. Pangalis; J.C. Reverter; V.A. Boussiotis; E. Montserrat. Chronic lymphocytic leukemia in younger adults:Preliminary results of a study based on 454 patients-IWCLL/working group. Leukemia and Lymphoma.5 - S1, pp. 175 - 178. 1991. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026347965&doi=10.3109%2f10428199109103401&partnerID=40&md5=912e582f1a65d5ae3791de07d8060949>.Type of production: Scientific paper Format: Journal

208 N. Villamor; J.C. Reverter; J.M. Marti; E. Montserrat; C. Rozman. Clinical features and responseto treatment of infradiaphragmatic Hodgkin's disease. European Journal of Haematology. 46- 1, pp. 38 - 41. 1991. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026027346&partnerID=40&md5=eb08ccf0aae9c41dcf471eb0532e985e>.Type of production: Scientific paper Format: Journal

209 J.C. Garcia Valdecasas; J.M. Llovera; A.M. deLacy; J.C. Reverter; L. Grande; J. Fuster; E. Cugat; J.Visa; C. Pera. Obstructing colorectal carcinomas - Prospective study. Diseases of the Colon & Rectum.34 - 9, pp. 759 - 762. 1991. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026076241&partnerID=40&md5=b2f7c960c797c610bebf1f42b7208b11>.Type of production: Scientific paper Format: Journal

210 J.L. Vives Corrons; I. Besson; A. Merino; J. Monteagudo; J.C. Reverter; J.L. Aguilar; C. Enrich. Occurrenceof hereditary leaky red cell syndrome and partial coagulation factor VII deficiency in a Spanish family. ActaHaematologica. 86 - 4, pp. 194 - 199. 1991. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026328984&partnerID=40&md5=291f2be1f020d56dfbd192acd15177a4>.Type of production: Scientific paper Format: Journal

211 E. Montserrat; F. Gomis; T. Vallespí; A. Ríos; A. Romero; J. Soler; A. Alcalá; M. Morey; C. Ferrén;J. Díaz Mediavilla; A. Flores; S. Woessner; J. Batlle; C. González Aza; M. Rovira; J.-C. Reverter; C.Rozman. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood.

ce46abfe1b997dc092066835783957ac

37

78 - 6, pp. 1545 - 1551. 1991. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0026091366&partnerID=40&md5=de37efa5652c8dfd4d560aeca9a8c331>.Type of production: Scientific paper Format: Journal

212 R.M. Martí; T. Estrach; J.C. Reverter; J.M. Mascaró. Prognostic ClinicopathologicFactors in Cutaneous T-cell Lymphoma. Archives of Dermatology. 127 - 10, pp. 1511- 1516. 1991. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026052528&doi=10.1001%2farchderm.1991.01680090075007&partnerID=40&md5=3d1713f8b7b262be6cae8aac28f6b96b>.Type of production: Scientific paper Format: Journal

213 J. Monteagudo; A. Pereira; J.C. Reverter; J. Pijoan; J. Tusell; L. Puig; A. Ordinas; R. Castillo. Thrombin generationand fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Thrombosis andHaemostasis. 66 - 5, pp. 515 - 519. 1991. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026043975&partnerID=40&md5=7369e10ec6f40f9765d95b04325dcc1e>.Type of production: Scientific paper Format: Journal

214 A. Cases; G. Escolar; J.C. Reverter; M. Garrido; A. Ordinas; J. Lopez Pedret; R. Castillo; L. Revert.Effect of human recombinant erythropoietin on primary hemostasia in uremic patients. Medicina Clinica.95 - 17, pp. 644 - 647. 1990. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0025709920&partnerID=40&md5=239be1a1abc2a0fb2f460093df73e269>.Type of production: Scientific paper Format: Journal

215 E. Montserrat; J.-M. Martí; J.-C. Reverter; C. Rozman. Efficacy of ABVD therapyin resistant hodgkin's disease. Leukemia and Lymphoma. 1 - 2, pp. 119 - 122.1990. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025341633&doi=10.3109%2f10428199009042468&partnerID=40&md5=e59bd4091cc93f5b2439180f7586e276>.Type of production: Scientific paper Format: Journal

216 J. Monteagudo; J.C. Reverter; D. Mateo; R. Seoane; R. Mazzara; G. Escolar; A. Pereira; R. Castillo; J. Visa.Intraoperative investigation of von Willebrand factor structure and function in orthotopic liver transplantation.Transplantation Proceedings. 22 - 4, pp. 1531 - 1532. 1990. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025157842&partnerID=40&md5=6d980abc360e3a44cc61a794d0404a68>.Type of production: Scientific paper Format: Journal

217 J. Monteagudo; A. Pereira; S. Roig; J.C. Reverter; A. Ordinas; R. Castillo. Investigation of plasma von Willebrandfactor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome. AmericanJournal of Hematology. 33 - 1, pp. 46 - 49. 1990. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0025058984&partnerID=40&md5=e90f14f9de34e85d7ee160edd6cf999e>.Type of production: Scientific paper Format: Journal

218 X. Calvet; J.C. Reverter; J. Blade; J.M. Pique; A. Mas; A. Rives; Y.J. Teres. Massive enterorrhagia afterrecovery of post-chemotherapy aplasia in a patient with acute leukemia [ENTERORRAGIA MASIVA TRASLA RECUPERACION DE AL APLASIA POSQUIMIOTERAPIA EN UN PACIENTE CON LEUCEMIA AGUDA].Gastroenterologia y Hepatologia. 13 - 1, pp. 20 - 22. 1990. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025267085&partnerID=40&md5=d6f175cd66a2822535c1bddcf8096a68>.Type of production: Scientific paper Format: Journal

219 S. Molica; J.C. Reverter; A. Alberti; E. Montserrat. Timing of diagnosis and lymphocyte accumulation patternsin chronic lymphocytic leukemia: Analysis of their clinical significance. European Journal of Haematology.44 - 5, pp. 277 - 281. 1990. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025175438&doi=10.1111%2fj.1600-0609.1990.tb00395.x&partnerID=40&md5=13c0abcf8958c05346c67673ac3c788f>.Type of production: Scientific paper Format: Journal

ce46abfe1b997dc092066835783957ac

38

220 C. Rozman; J.-C. Reverter; E. Feliu; L. Berga; M. Rozman; C. Climent. Variations of fat tissue fractionin abnormal human bone marrow depend both on size and number of adipocytes: A stereologic study.Blood. 76 - 5, pp. 892 - 895. 1990. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024989037&partnerID=40&md5=dad9c8e69a3bfb7569102cf921eb1478>.Type of production: Scientific paper Format: Journal

221 J. Bladé; C. Rozman; F. Cervantes; J.?C. Reverter; E. Montserrat. A new prognostic system formultiple myeloma based on easily available parameters. British Journal of Haematology. 72 -4, pp. 507 - 511. 1989. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024458105&doi=10.1111%2fj.1365-2141.1989.tb04314.x&partnerID=40&md5=f7b7cdd74b259e5e67cbb660f5dbc927>.Type of production: Scientific paper Format: Journal

222 J.-M. Ribera; F. Gervantes; J.-C. Reverter; E. Montserrat; C. Rozman. Acute transformation of chronicmyelomonocytic leukaemia: A multivariate study of predictive factors. European Journal of Haematology.42 - 3, pp. 284 - 288. 1989. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0024589846&partnerID=40&md5=bc45fbd2f505f2af8a765f334238a2c9>.Type of production: Scientific paper Format: Journal

223 C. Rozman; E. Feliu; L. Berga; J.-C. Reverter; C. Climent; M.-J. Ferran. Age-related variations of fat tissue fractionin normal human bone marrow depend both on size and number of adipocytes: a stereological study. ExperimentalHematology. 17 - 1, pp. 34 - 37. 1989. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024496975&partnerID=40&md5=ba093f51402d1b7dfca4fb105dc7d6af>.Type of production: Scientific paper Format: Journal

224 A. Pereira; J. Monteagudo; M. Rovira; R. Mazzara; J.C. Reverter; R. Castillo. Anti-K1of the IgA class associated with Morganella morganii infection. Transfusion. 29 - 6, pp.549 - 551. 1989. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0024364348&partnerID=40&md5=b6315227e27bcdfa7caec8a0404302c8>.Type of production: Scientific paper Format: Journal

225 M. Rovira; F. Cervantes; M. Lozano; J.M. Ribera; J.C. Reverter; C. Rozman. Chronicmyelomonocytic leukemia and solid neoplasms: is it a causal or a fortuitous association? [Leucemiamielomonocítica crónica y neoplasias sólidas: Asociación causal o fortuita?]. Sangre. 34 - 3,pp. 207 - 209. 1989. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-17344380728&partnerID=40&md5=911ba739357324c1226aadfb79db12a6>.Type of production: Scientific paper Format: Journal

226 E. Carreras; N. Villamor; J.C. Reverter; J. Sierra; A. Granena; C. Rozman. Hypertriglyceridemia in bonemarrow transplant recipients: Another side effect of cyclosporine A. Bone Marrow Transplantation.4 - 4, pp. 385 - 388. 1989. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024430530&partnerID=40&md5=b5899c39cca76be3c301259fffff6d32>.Type of production: Scientific paper Format: Journal

227 A. López Guillermo; J.C. Reverter; F. Cervantes; N. Viñolas; M. Rovira; A. Urbano Ispizua; E. Montserrat; C.Rozman. Neoplasms associated with chronic lymphatic leukemia. Incidence and characteristics in a series of 232patients [Neoplasias asociadas a la leucemia linfática crónica. Incidencia y características en una serie de 232pacientes.]. Medicina clinica. 93 - 18, pp. 681 - 683. 1989. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0024959981&partnerID=40&md5=2ebe52f8aec328d69ff7e8ce01086f50>.Type of production: Scientific paper Format: Journal

228 F. Cervantes; J.C. Reverter; J. Blade; E. Montserrat; C. Rozman. CEP (CCNU, VP-16 and prednimustine)therapy for Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients. Sangre. 33- 3, pp. 184 - 187. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024025559&partnerID=40&md5=0e26c6fc98312202f11790886aa9a26c>.

ce46abfe1b997dc092066835783957ac

39

Type of production: Scientific paper Format: Journal

229 M. Aymerich; J.M. Jou; J.L. Vives Corrons; M.J. Insa; J.C. Reverter; C. Pastor. Evaluation of the SysmexE-4000 autoanalyser at a university hospital [Evaluación del autoanalizador Sysmex E-4000 en un hospitaluniversitario.]. Sangre. 33 - 1, pp. 1 - 7. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023954304&partnerID=40&md5=276ba04909908e751f45f9c24df6b830>.Type of production: Scientific paper Format: Journal

230 J.C. Reverter; B. Nomdedeu; E. Martin Ortega; C. Llebaria; J. Palou; C. Rozman. GeneralizedCastleman's disease associated to Kaposi's sarcoma. Revista Clinica Espanola. 182 - 4,pp. 206 - 209. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023820582&partnerID=40&md5=cbaf30b7838a95c11c03711b5c6051fa>.Type of production: Scientific paper Format: Journal

231 J.C. Reverter; J. Sierra; J.M. Marti Tutusaus; E. Montserrat; A. Granena; C. Rozman.Hypocholesterolemia in acute myelogenous leukemia. European Journal of Haematology. 41 -4, pp. 317 - 320. 1988. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0024273861&partnerID=40&md5=21cc0776b960db607d2202507c44fea7>.Type of production: Scientific paper Format: Journal

232 F. Cervantes; J.-M. Marti; C. Piera; J.-C. Reverter; C. Rozman. Longitudinal study of serumferritin concentrations in chronic granulocytic leukaemia. Acta Haematologica. 80 - 1, pp.13 - 16. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023748356&partnerID=40&md5=bcc73c9902f36dffbc667d94b33a02ef>.Type of production: Scientific paper Format: Journal

233 E. Montserrat; N. Vinolas; J.C. Reverter; C. Rozman. Natural history of chronic lymphocytic leukemia:On the progression and prognosis of early clinical stages. Nouvelle Revue Francaise d'Hematologie.30 - 5-6, pp. 359 - 361. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024255987&partnerID=40&md5=d7384a79955662ca457728abcaec8da5>.Type of production: Scientific paper Format: Journal

234 J. Bladé; C. Rozman; J.C. Reverter; E. Montserrat. Prognosis factors in multiple myeloma[Factores pronósticos en el mieloma múltiple.]. Revista Clinica Espanola. 183 - 4, pp.215 - 215. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024085984&partnerID=40&md5=78cc42f0cfe51e786fbad4bbdc5bf129>.Type of production: Scientific paper Format: Journal

235 C. Rozman; E. Feliu; L. Berga; J.C. Reverter; C. Climent; M.J. Ferrán. Stereologic study of the fat cells inhuman bone marrow [Estudio estereológico de las células grasas en la medulla ósea humana.]. Sangre.33 - 3, pp. 206 - 210. 1988. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024027091&partnerID=40&md5=d55eaaacb1f7c70b1b7edfbdcc8a5399>.Type of production: Scientific paper Format: Journal

236 J.C. Reverter; A. Coca; J. Font; M. Ingelmo. Erythema nodosum and pulmonary solitary nodule asthe first manifestations of a non-Hodgkin's lymphoma. British Journal of Diseases of the Chest. 81- C, pp. 397 - 399. 1987. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023627791&doi=10.1016%2f0007-0971%2887%2990189-6&partnerID=40&md5=18223478248b5e9caf4f87305d28c902>.Type of production: Scientific paper Format: Journal

237 J.C. Reverter; J.M. Ribera; B. Nomdedeu; C. Rozman. Hypertrophic osteoarthropathy associated withHodgkin's disease [Osteoartropatía hipertrófica asociada a enfermedad de Hodgkin.]. Medicina Clinica.88 - 6, pp. 259 - 259. 1987. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023652961&partnerID=40&md5=91c0df922d300f125ba58895a3d4546f>.

ce46abfe1b997dc092066835783957ac

40

Type of production: Scientific paper Format: Journal

238 N. Vinolas; J.C. Reverter; A. Urbano Ispizua; E. Montserrat; C. Rozman. Lymphocyte doublingtime in chronic lymphocytic leukemia: An update of its prognostic significance. Blood Cells. 12- 2, pp. 457 - 464. 1987. Available on-line at: <http://www.scopus.com/inward/record.url?eid=2-s2.0-0023238562&partnerID=40&md5=cfef367815f370e59049c3ea93a8e493>.Type of production: Scientific paper Format: Journal

239 A. Merino; L. Vives Corrons; J.L. Aguilar i Bascompte; L. Berga; J.C. Reverter. Study of erythrocyteion permeability in hereditary spherocytosis: contribution to its diagnosis [Estudio de la permeabilidadiónica eritrocitaria en la esferocitosis hereditaria: contribución a su diagnóstico.]. Sangre. 32 -3, pp. 323 - 332. 1987. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-19244376459&partnerID=40&md5=bf9ef57e8c85bca584e285d68b7f7bf4>.Type of production: Scientific paper Format: Journal

240 J.C. Reverter; N. Vinolas; E. Montserrat; C. Rozman. Hodgkin's disease in external mammary lymph nodes.Annalsof Internal Medicine. 103 - 6, 1985. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-17744416480&partnerID=40&md5=f182951acfaa9e5de61e9cd8b3fcfcce>.Type of production: Scientific paper Format: Journal

241 J.C. Reverter; A. Serra; V. Valls. Intestinal angiodysplasia associated with an aortic stenosis[Angiodisplasia intestinal asociada a estenosis aórtica.]. Medicina Clinica. 84 - 6, pp.249 - 250. 1985. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022427226&partnerID=40&md5=787b59d307130c2a5db0dfdca20c2a71>.Type of production: Scientific paper Format: Journal

242 J.C. Reverter; J. Font; A. Coca. Hypothyroidism secondary to a lengthy treatment with lithium carbonate[HIPOTIROIDISMO SECUNDARIO A TRATAMIENTO PROLONGADO CON CARBONATO DE LITIO]. MedicinaClinica. 81 - 15, pp. 695 - 696. 1983. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021101889&partnerID=40&md5=4f52c85083b93da00289c3605b5fdfb7>.Type of production: Scientific paper Format: Journal

243 R Cervera; I Rodríguez-Pintó; G Espinosa; JC Reverter. Thrombotic Manifestations of theAntiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases. 12, pp. 87 -106. Elsevier, 2016. Available on-line at: <https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016743550&doi=10.1016%2fB978-0-444-63655-3.00006-5&partnerID=40&md5=e9955af90f58da68d3d5a36589a3e784>.ISSN 1571-5078, ISBN 978-0-444-63655-3Type of production: Book chapter Format: BookPosition of signature: 4Total no. authors: 4

ce46abfe1b997dc092066835783957ac

41

R&D management and participation in scientific committees

Scientific, technical and/or assessment committees

1 Committee title: Tesorero del Comité de Estandarización en HematologíaPrimary (UNESCO code): 320504 - HaematologyAffiliation entity: Asociación Española de Hematología y Hemoterapia (AEHH)City affiliation entity: SpainStart-End date: 1988 - 2000

2 Committee title: "Task Force on Platelet Immunophenotyping and Function Assays"Affiliation entity: European Working Group onClinical Cell Analysis

Type of entity: Associations and Groups

Start-End date: 1996 - 1996

3 Committee title: Presidente del Comité de Estandarización en HematologíaAffiliation entity: Sociedad Española de Hematología y HemoterapiaCity affiliation entity: SpainStart date: 01/01/2000

4 Committee title: Comité responsable de los programas de Garantia de la Qualitat del EQAS for ClinicalLaboratories in Europe del programa Measuring & Testing de la Comunidad Europea (CE)Primary (UNESCO code): 320504 - HaematologyStart date: 1988

Other achievements

Stays in public or private R&D centres

Entity: Mount Sinai School Of Medicine (Mount SinaiMedical Center)

Type of entity: Healthcare Institutions

Faculty, institute or centre: School of MedicineCity of entity: Nueva York, United States of AmericaStart-End date: 01/1994 - 01/1995 Duration: 1 yearGoals of the stay: FormaciónProvable tasks: Research Assistant Professor de la City University of New York

Scientific societies and professional associations

1 Name of the society: Presidente de la Sociedad Española de Trombosis y HemostasiaStart-End date: 29/10/2020 - 25/10/2024

2 Name of the society: Presidente de la Sociedad Catalana de Hematología y HemoterapiaCity affiliation entity: Barcelona, Catalonia, SpainStart-End date: 01/01/2008 - 01/01/2011

ce46abfe1b997dc092066835783957ac

42

3 Name of the society: Secretario de la Sociedad Española de Trombosis y HemostasiaCity affiliation entity: SpainStart-End date: 01/01/2003 - 01/01/2010

4 Name of the society: Vocal de la Junta de la Sociedad Española de Trombosis y HemostasiaCity affiliation entity: SpainStart-End date: 01/01/2001 - 01/12/2003

5 Name of the society: Secretario de la Sociedad Española de Trombosis y HemostasiaCity affiliation entity: SpainStart date: 01/01/2019

Co-operation networks

Name of the network: Red HERACLES de Investigación cardiovascular (RETIC) en el grupoHemato-IDIBAPS. Investigador de la beca de la Red HERACLES, Ministerio de Ciencia e Innovación.Instituto de Salud Carlos III, dentro del grupo Hemato-IDIBAPS.Identification of the network: RD06/0009/1003.Participating entity/entities: CENTRO DE ACUSTICA APLICADA Y EVALUACION NO DESTRUCTIVA

Prizes, mentions and distinctions

1 Description: Premio de la Asociación Española de Hematología y Hemoterapia a la mejor publicaciónen ‘Haematologica’ por el trabajo: Tàssies D, Freire C, Pijoan J, Maragall S, Monteagudo J, Ordinas A,Reverter JC. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influencedose requirements and stability of anticoagulation. Haematologica 2002 ; 87: 1185-1191.Awarding entity: Asociación Española deHematología y Hemoterapia

Type of entity: Asociacion médica

City awarding entity: Madrid, Catalonia, SpainConferral date: 15/06/2002

2 Description: Premio de la Societat de Medicina Interna de la Acadèmia de Ciències Mèdiques deCatalunya i Balears a la mejor publicación científica de l’any 2002 per el trabajo: Vascular involvementin Behçet’s Disease: Relationship with thrombophilic factors, coagulation activation and thrombomodulin.Autores: Espinosa G, Font J, Tàssies D, Vidaller A, Deulofeu R, López-Soto A, Cervera R, Ordinas A,Ingelmo M, Reverter JCAwarding entity: Sociedad de Medicina Interna de la Acadèmia de Ciències Mèdiques de Catalunya iBalears a la mejor publicación científica del añoCity awarding entity: Barcelona, Catalonia, SpainConferral date: 15/06/2002

3 Description: Premio de la Sociedad Europea de Anestesia Regional por el mejor trabajo del IV Congresode ESRA (Sociedad Europea de Anestesia Regional) Local Meeting pel estudi Eficacia y toxicidad de laanalgesia peridural controlada por la paciente en obstetricia. Autors: Plaza A, Fernández C, Taurá P, GomarC, Reverter JC.Awarding entity: Sociedad Europea de Anestesia RegionalCity awarding entity: Vigo, Galicia, SpainConferral date: 15/10/1998

ce46abfe1b997dc092066835783957ac

43

4 Description: VI Premio de Investigació Shering-Plough Liga Española para la Lucha Contra la HipertensiónArterial per el trebajo: Síndrome de apneas obstructivas durante el sueño, hipertensión arterial y riesgocardiovascular: estudio fisiopatológicoAwarding entity: Liga Española para la LuchaContra la Hipertensión Arterial

Type of entity: Associations and Groups

City awarding entity: Madrid, Community of Madrid, SpainConferral date: 15/04/1995

5 Description: ASH Travel Award (American Society of Hematology) per la presentació "Platelet glycoproteinIIb/IIIa inhibition decreases thrombin generation induced by tissue factor"Awarding entity: 36th Annual Meeting AmericanSociety of Hematology

Type of entity: Associations and Groups

City awarding entity: Nashville, United States of AmericaConferral date: 15/12/1994

6 Description: II Premio Extraordinario sobre Eritropoyetina por el trabajo: Efecto del tratamiento coneritropoyetina recombinante humana para la correción de la anemia renal sobre la hemostasia primaria enlos pacientes urémicos. Autors: Cases A, Escolar G, Reverter JC, Tàssies D, López-Pedret J, Ordinas A,Castillo R, Revert Ll.Awarding entity: XXIII Reunión Nacional de laSociedad Española de Nefrología

Type of entity: Associations and Groups

City awarding entity: Madrid, Community of Madrid, SpainConferral date: 15/11/1991